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selbstständig verfasst, mich außer der angegebenen keiner weiteren Hilfsmittel bedient
und alle Erkenntnisse, die aus dem Schrifttum ganz oder annähernd übernommen sind,
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Behrens I-K, Busch B, Ishikawa-Ankerhold H, Palamides P, Shively JE, Stanners C,
Chan C, Leung N, Gray-Owen S, Haas R. 2020. The HopQ-CEACAM interaction con-
trols CagA translocation, phosphorylation, and phagocytosis of Helicobacter pylori in
neutrophils. mBio 11:e03256-19. https://doi.org/10.1128/mBio.03256-19.
Weitere Publikationen im Promotionszeitraum, die nicht in dieser Arbeit ent-
halten sind:
- Zhang J, Wieser A, Lin H, Li H, Hu M, Behrens I-K, Schiergens T, Mayerle J, Gerbes A,
Steib C. 2020. Kupffer cell activation by different microbial lysates: Toll-like receptor-2
plays pivotal role on thromboxane A2 production in mice and humans. Eur J Immunol.
doi: 10.1002/eji.201948507
- Jagau H, Behrens I-K, Steinert M, Bergmann S. 2019. Pneumococcus Infection of
Primary Human Endothelial Cells in Constant Flow, J. Vis. Exp., e60323
doi:10.3791/60323
CONTENTS
Contents
ABSTRACT 1
ZUSAMMENFASSUNG 2
1 Introduction 4
1.1 Neutrophil Granulocytes . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4
1.1.1 Origin and development of neutrophils and other myeloid leukocytes 5
1.1.2 Neutrophil recruitment and chemokine production . . . . . . . . . . 6
1.1.3 Phagocytosis and production of reactive oxygen species . . . . . . . 7
1.2 The pathogen - Helicobacter pylori . . . . . . . . . . . . . . . . . . . . . . 8
1.2.1 Clinical manifestation and treatment . . . . . . . . . . . . . . . . . 8
1.2.2 Colonization of the human stomach by H. pylori . . . . . . . . . . . 9
1.2.3 CagA - The oncoprotein of H. pylori . . . . . . . . . . . . . . . . . 9
1.3 Immune response to H. pylori . . . . . . . . . . . . . . . . . . . . . . . . . 12
1.3.1 Massive recruitment of neutrophils . . . . . . . . . . . . . . . . . . 13
1.3.2 Manipulation of macrophages and DCs . . . . . . . . . . . . . . . . 14
1.3.3 Downregulation of the adaptive immune response by T-cells . . . . 15
1.4 CEACAMs . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 15
1.4.1 Structure and function of CEACAMs . . . . . . . . . . . . . . . . . 16
1.4.2 Human CEACAM1 . . . . . . . . . . . . . . . . . . . . . . . . . . . 17
1.4.3 Human CEACAM3 . . . . . . . . . . . . . . . . . . . . . . . . . . . 18
1.4.4 Human CEACAM6 . . . . . . . . . . . . . . . . . . . . . . . . . . . 18
1.4.5 Murine CEACAM1 and 2 . . . . . . . . . . . . . . . . . . . . . . . 19
1.4.6 H. pylori - CEACAM interaction . . . . . . . . . . . . . . . . . . . 20
1.5 H. pylori infection model systems . . . . . . . . . . . . . . . . . . . . . . . 21
1.6 Aims of this work . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 22
2 Material and methods 23
2.1 Isolation and cultivation of cells . . . . . . . . . . . . . . . . . . . . . . . . 23
2.1.1 Mouse lines . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 23
2.1.2 Isolation of murine neutrophils . . . . . . . . . . . . . . . . . . . . . 24
i
CONTENTS
2.1.3 Isolation of human neutrophils . . . . . . . . . . . . . . . . . . . . . 24
2.1.4 Isolation of murine DCs and MΦ . . . . . . . . . . . . . . . . . . . 24
2.1.5 Isolation of human DCs and MΦ . . . . . . . . . . . . . . . . . . . 25
2.1.6 Cell lines and their cultivation . . . . . . . . . . . . . . . . . . . . . 26
2.1.7 Immortalization and differentiation of cells . . . . . . . . . . . . . . 28
2.1.8 Cryoconservation of cells . . . . . . . . . . . . . . . . . . . . . . . . 28
2.1.9 Generation of ER-Hoxb8 neutrophil cell lines . . . . . . . . . . . . . 28
2.2 Microbiological methods . . . . . . . . . . . . . . . . . . . . . . . . . . . . 29
2.2.1 Bacterial strains . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 29
2.2.2 Cultivation of bacteria . . . . . . . . . . . . . . . . . . . . . . . . . 31
2.2.3 Cryoconservation of bacteria . . . . . . . . . . . . . . . . . . . . . . 31
2.3 In vitro infection . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 31
2.3.1 Survival assay . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 31
2.4 Biochemical methods . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 32
2.4.1 Bacterial and cellular lysates . . . . . . . . . . . . . . . . . . . . . . 32
2.4.2 Sodium dodecyl sulfate polyacrylamide gel electrophoresis . . . . . 32
2.4.3 Immunoblot . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 33
2.4.4 CagA phosphorylation . . . . . . . . . . . . . . . . . . . . . . . . . 35
2.4.5 Antibodies - Immunoblots . . . . . . . . . . . . . . . . . . . . . . . 35
2.4.6 In vitro phosphorylation . . . . . . . . . . . . . . . . . . . . . . . . 36
2.4.7 Src homology protein tyrosine phosphatase-1 inhibition . . . . . . . 37
2.5 Flow cytometry . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 37
2.5.1 Antibodies - flow cytometry . . . . . . . . . . . . . . . . . . . . . . 37
2.5.2 Cell characterization . . . . . . . . . . . . . . . . . . . . . . . . . . 38
2.5.3 CEACAM expression . . . . . . . . . . . . . . . . . . . . . . . . . . 38
2.5.4 Interaction experiment . . . . . . . . . . . . . . . . . . . . . . . . . 38
2.5.5 Binding assay . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 38
2.5.6 Phagocytosis assay . . . . . . . . . . . . . . . . . . . . . . . . . . . 39
2.5.7 Detection of ROS . . . . . . . . . . . . . . . . . . . . . . . . . . . . 39
2.5.8 Quantification of CagA translocation . . . . . . . . . . . . . . . . . 39
2.5.9 Chemokine measurement . . . . . . . . . . . . . . . . . . . . . . . . 40
2.6 Microscopy . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 40
2.6.1 Confocal microscopy of H. pylori - neutrophil interaction . . . . . . 40
2.6.2 Giemsa staining . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 41
2.7 CRISPR/Cas9 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 41
2.8 2D migration . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 44
2.9 Statistics . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 44
ii
CONTENTS
3 Results 45
3.1 The role of human CEACAMs for the interaction of H. pylori with neutrophils 45
3.1.1 CEACAM expression in neutrophils . . . . . . . . . . . . . . . . . . 45
3.1.2 Interaction of H. pylori with neutrophils . . . . . . . . . . . . . . . 47
3.1.3 Binding versus phagocytosis of H. pylori . . . . . . . . . . . . . . . 50
3.1.4 Survival of H. pylori after phagocytosis by PMNs . . . . . . . . . . 51
3.1.5 Production of reactive oxygen species . . . . . . . . . . . . . . . . . 53
3.1.6 Confocal microscopy studies of the interaction of H. pylori and PMNs 54
3.1.7 The role of human CEACAMs on CagA translocation and phospho-
rylation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 56
3.1.8 Influence of SHP-1 on CagA phosphorylation . . . . . . . . . . . . . 59
3.1.9 2D migration of murine and humanized PMNs . . . . . . . . . . . . 60
3.2 The role of human CEACAMs on the secretion of chemokines . . . . . . . 62
3.2.1 Chemokine secretion of PMNs infected with H. pylori . . . . . . . 62
3.2.2 Chemokine secretion of DCs and MΦ infected with H. pylori . . . . 63
3.3 Interaction of H. pylori with DCs and MΦ . . . . . . . . . . . . . . . . . . 65
3.3.1 CEACAM expression of DCs and MΦ . . . . . . . . . . . . . . . . . 65
3.3.2 Interaction of H. pylori with DCs and MΦ . . . . . . . . . . . . . . 67
3.3.3 CagA translocation and phosphorylation . . . . . . . . . . . . . . . 67
3.4 Impact of a chronic infection with H. pylori on the interaction with neu-
trophils . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 69
3.4.1 Effect on CagA translocation and phosphorylation . . . . . . . . . . 69
3.4.2 Effect on CEACAM expression . . . . . . . . . . . . . . . . . . . . 72
4 Discussion 74
4.1 H. pylori interacts with human CEACAMs to manipulate neutrophils . . . 75
4.1.1 CEACAMs facilitate survival of phagocytosis . . . . . . . . . . . . 76
4.1.2 CEACAMs enable CagA phosphorylation in PMNs . . . . . . . . . 78
4.1.3 H. pylori-CEACAM interactions change the chemokine secretion of
neutrophils . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 80
4.1.4 The role of CEACAM3 in a H. pylori infection . . . . . . . . . . . . 81
4.1.5 CEACAMs play a major role on PMNs rather than on MΦ and DCs 81
4.1.6 Characterization of PMNs from naive versus H. pylori-infected hosts 83
4.2 Conclusion and outlook . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 84
LIST OF ABBREVIATIONS 85
LIST OF FIGURES 89
LIST OF TABLES 91
iii
CONTENTS
LITERATURE 92
ACKNOWLEDGEMENT 109
iv
ABSTRACT
Abstract
Despite a strong immune response H. pylori persists for decades in the human
stomach. The bacterium actively manipulates immune cells resulting in massive infiltra-
tion of neutrophil granulocytes (neutrophils) leading to tissue damage. H. pylori injects
the cytotoxin-associated gene A (CagA), a bacterial oncoprotein, via its type IV secretion
system into gastric epithelial cells, where it gets phosphorylated and activates intracellu-
lar signaling cascades. This procedure can promote various malignancies, such as gastric
cancer and is the reason for the classification of H. pylori as a class I carcinogen by the
world health organization (WHO). However, the infection of mice with H. pylori, which
is only possible by a mouse adapted H. pylori strain, results in a mild pathology. Humans
express several carcinoembryonic antigen-related cell adhesion molecules (CEACAMs) on
the surface of different cells. These glycoproteins function as pathogen receptors for sev-
eral human pathogens and influence signaling pathways. For H. pylori human CEACAMs
are essential to translocate CagA into gastric epithelial cells, while murine CEACAMs do
not function as receptors for the bacterium. The aim of this thesis was to analyze the role
of human CEACAMs for the interaction of H. pylori with neutrophils. Thus, experiments
with neutrophils and other myeloid cells isolated from mice expressing human CEACAM
receptors (CEACAM-humanized mice) were performed.
It was found that H. pylori efficiently interacts with CEACAMs on neutrophils. Notably,
human CEACAMs enable the CagA phosphorylation in murine neutrophils and increase
the secretion of the proinflammatory chemokine MIP-1α, which might lead to a stronger
infiltration of immune cells into the mouse stomach. Furthermore, an increased oxidative
burst and high survival rates of H. pylori were detected in humanized CEACAM3 and
6 neutrophils, providing a possible explanation for the inefficiency of neutrophils in bac-
terial clearance. In addition, in vivo data demonstrated a down-regulation of CEACAM
expression in neutrophils from chronically infected mice.
In conclusion, these data provide new insights into the interaction of H. pylori with neu-
trophils extending our knowledge about bacterial manipulation of the immune response.
Moreover, this work highlights the important function of CEACAMs on neutrophils in
a H. pylori infection, which generally strengthens the role of CEACAMs for pathogens
and recommends the humanized CEACAM mouse as a new model organism in H. pylori
infection research.
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Zusammenfassung
Trotz einer starken Immunantwort überdauert H. pylori für Jahrzehnte im menschlichen
Magen. Das Bakterium manipuliert aktiv Immunzellen, was zu einer massiven Einwan-
derung von neutrophilen Granulozyten (Neutrophilen) führt, die das Gewebe schädigen.
H. pylori injiziert das Zytotoxin-assoziierte Genprodukt A (CagA) mit seinem Typ IV
Sekretionssystem in die Magenepithelzellen, wo dieses phosphoryliert wird und intrazel-
luläre Signalkaskaden aktiviert. Dies fördert die Entstehung von Entzündungen (Gastritis)
sowie verschiedener Erkrankungen wie Magenkrebs und ist der Grund für die Einstufung
von H. pylori durch die Weltgesundheitsorganisation als Klasse I krebserregendes Bak-
terium. In der Maus hingegen, die überhaupt nur mit an die Maus adaptierten H. pylori
Stämmen infiziert werden kann, verursacht H. pylori nur eine milde Pathologie. Men-
schen exprimieren unterschiedliche Zelladhäsionsmoleküle der karzinoembryonalen Anti-
genfamilie (CEACAMs) auf der Oberfläche verschiedener Zellen. Diese Glykoproteine
dienen verschiedenen humanen Pathogenen als Rezeptoren und beeinflussen zelluläre Sig-
nalwege. Für H. pylori sind humane CEACAMs essentiell für die Injektion von CagA in
Magenepithelzellen, wohingegen murine CEACAMs für das Bakterium nicht als Rezeptor
fungieren. Das Ziel dieser Arbeit war es, die Rolle von humanen CEACAMs für die In-
teraktion von H. pylori mit Neutrophilen zu analysieren. Dafür wurden Experimente mit
Neutrophilen und anderen myeloiden Zellen von Mäusen, die humane CEACAM Rezep-
toren exprimieren (humanisierte CEACAM Mäuse) durchgeführt.
Es konnte gezeigt werden, dass H. pylori effizient mit CEACAMs auf Neutrophilen in-
teragiert. Bemerkenswerterweise ermöglichen humane CEACAMs die CagA Phospho-
rylierung in murinen Neutrophilen und erhöhen die Menge des proinflammatorischen
Chemokines MIP-1α, was wahrscheinlich zu einer stärkeren Einwanderung von Immun-
zellen in den Magen führt. Zudem wurde in humanisierten CEACAM3 und 6 Neutrophilen
eine stärkere Produktion von reaktiven Sauerstoffen und eine erhöhte Überlebensrate von
H. pylori festgestellt. Dies könnte eventuell erklären, warum die Neutrophilen das Bak-
terium nicht abtöten und eliminieren konnten. Zusätzlich zeigten in vivo Daten, dass in
Neutrophilen von chronisch mit H. pylori infizierten Mäusen die Expression von CEA-
CAMs herunter reguliert ist.
Zusammenfassend bietet diese Arbeit neue Einblicke in die Interaktion von H. pylori
mit Neutrophilen und erweitert das Wissen, wie das Bakterium die Immunantwort ma-
2
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nipuliert. Zudem verdeutlicht dieses Projekt die wichtige Funktion von CEACAMs auf
Neutrophilen für eine H. pylori Infektion, wodurch generell die Rolle von CEACAMs für
Pathogene unterstrichen und die humanisierte CEACAM-Maus als neuer Modelorganis-
mus in der H. pylori Forschung ausgewiesen wird.
3
1. INTRODUCTION
1. Introduction
1.1 Neutrophil Granulocytes
No mammal, including humans, can win a battle against pathogens without or with a
significantly reduced number of neutrophil granulocytes (generally termed neutrophils in
this thesis) [1]. These cells represent the first line of defense against invading pathogens.
They are recruited as the first immune cells to the site of infection or inflammation. There,
neutrophils release reactive oxygen species (ROS) and kill invading bacteria. However, at
the same time, the surrounding tissue is damaged as well. Therefore, the degradation of
neutrophils is as important as their presence. Apoptotic signals cause them to be killed by
themselves or by monocytes, in order to prevent the destruction of tissue by their release
of toxic chemicals. A further task of neutrophils is the secretion of proinflammatory
chemokines, whereby further immune cells are recruited to the site of infection. For
many years it has been claimed that neutrophils have a short lifespan and that their only
function is the phagocytosis of invading pathogens in an acute infection. Recent studies
showed that neutrophils are much more complex. Murine neutrophils have a lifetime of
up to 12.5 h (hours) and human neutrophils survive up to 5.4 days [2]. Characteristic for
differentiated neutrophils is their
polymorph-segmented nucleus (see
Fig. 1.1 showing a neutrophil stained
with Giemsa). Therefore, these leuko-
cytes were also called polymorphonu-
clear granulocytes (PMNs). Hyper-
segmentation occurs during differen-
tiation. The nucleus of a PMN has
a size about 10 µm. Biochemically,
PMNs can be identified by CD66abce
(human) and Ly6G in combination
with the cluster of differentiation
(CD)11b (murine).
Fig. 1.1: Differentiated neutrophils
stained with Giemsa solution
Staining of differentiated murine neutrophils with
Giemsa shows the polymorph-segmented nuclei.
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1.1.1 Origin and development of neutrophils and other myeloid
leukocytes
With 50-70%, neutrophils represent the largest group of leukocytes, also known as white
blood cells, in the human organism. In mice, however, neutrophils constitute only 10-25%
of the leukocyte population [3]. Compared to other blood components such as blood
platelets, leukocytes join their nuclei. Because of their structure, they are divided into
granulocytes, monocytes and lymphocytes. Leukocytes originate from hematopoietic stem
cells in the bone marrow. These stem cells can differentiate into a lymphoid or myeloid
precursor cell. A lymphoid precursor cell develops into a lymphocyte. These include
B-cells, T-cells and natural killer cells. With 75-90%, lymphocytes represent the most
frequent cell type of leukocytes in mice [3].
Myeloid precursor cells develop, driven by granulocyte macrophage colony stimulating
factor (GM-CSF) and granulocytes colony stimulating factor (G-CSF) into myeloblasts
(see Fig. 1.2). Myeloblasts can transform into granulocytes or monocytes. Stem cell
factor (SCF), GM-CSF, G-CSF, interleukin (IL)-3 and IL-6 influence the development
into granulocytes, whereas SCF, GM-CSF, M-CSF, IL-3 and IL-6 result in development
of monocytes. Monocytes generally develop, stimulated by M-CSF into macrophages
(MΦ) or by GM-CSF into dendritic cells (DCs) (see Fig. 1.2) [4].
hematopoietic 
stem cell
myeloid 
precursor 
cell
neutrophil
monocyte
bone 
marrow
myeloblast
macrophage
dendritic cell
…
GM-CSF
G-CSF
SCF
GM-CSF
G-CSF
IL-3
IL-6
SCF
GM-CSF
M-CSF
IL-3
IL-6
granulocytes
…
…
M-CSF
GM-CSF
Fig. 1.2: Hematopoiesis of neutrophils, MΦ and DCs
Neutrophils originate from hematopoietic stem cells, which develop into a myeloid precursor cell and sub-
sequently into myeloblasts. Myeloblasts can mature to granulocytes such as neutrophils or to monocyte.
Monocytes develop into MΦ or DCs. Modified according to [4].
Granulocytes is the group name for neutrophils, eosinophils and basophils. According to
their name they are characterized by their “granules” in the cytoplasm. Eosinophils and
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basophils circulate in the blood to protect against parasites, while neutrophils circulate
in the blood and transmigrate into the tissue to protect against bacteria and fungi.
1.1.2 Neutrophil recruitment and chemokine production
After their generation in the thymus and bone marrow, neutrophils circulate in the blood
and lymphatic system and are in principal able to reach any location in the organism.
Neutrophils find their way to the site of an infection along a gradient of increasing con-
centrations of chemical attractants. These can originate from bacteria, or be secreted
by cells. An effective, rapidly produced chemoattractant for neutrophils is the proin-
flammatory lipid mediator leukotriene B4 (LTB4). LTB4 functions as an intracellular
communication signal between neutrophils and triggers swarming of neutrophils [5].
Apart from proinflammatory lipid mediators, also special cytokines, called chemokines,
are able to attract different cell populations. For that, their signals function through
G-protein-coupled receptor interactions. In general, chemokines can be divided into two
groups, CXC and CC chemokines, depending on their amino acid composition. The most
important chemokine for the recruitment of neutrophils in humans is IL-8, also known as
CXC motif chemokine 8 (CXCL8) (see Tab. 1.1) [6], [7], [8]. Rodents lack the human IL-8
gene [9]. In mice the ceratinocyte chemoattractant (KC)/CXCL1 and the macrophage
inflammatory protein 2 (MIP2)/CXCL2 are important chemokines for the recruitment of
neutrophils [10], [8], [11], [12]. They are secreted by resident cells and invading leukocytes.
Tab. 1.1: Chemokines attracting neutrophils to the site of infection
chemokine organism secreted by to attract reference
IL-8 (CXCL8) human residente cells and neutrophils [6], [7], [8]
invading leukocytes
KC (CXCL1) murine residente cells and neutrophils [10], [8]
invading leukocytes
MIP2 (CXCL2) murine residente cells neutrophils [11], [12], [8]
invading leukocytes
Murine neutrophils themselves secrete the macrophage inflammatory protein-1 (MIP-
1α)/CCL3, the macrophage inflammatory protein-1 beta (MIP-1β)/CCL4, the monokine
induced by gamma-interferon (MIG)/CXCL9 and the interferon-gamma induced protein
10 kDa (IP-10)/CXCL10 (see Tab. 1.2) [13], [14], [15]. For MIP1-α Charmoy et al. could
show that the protein is important for the recruitment of DCs. Pharmacological and
6
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genetic inhibition of MIP-1α leads to a considerable reduction of the number of recruited
DCs [14]. For MIP-1α and β, Stebut et al. could demonstrate that neutrophils regulate
MΦ recruitment by secretion of MIP1α and β [15]. Moreover, neutrophils are able to
secrete MIG and IP-10 by stimulation with interferon γ in combination with lipopolysac-
charide (LPS) or tumor necrosis factor (TNF)α [16], [17].
Tab. 1.2: Chemokines secreted by neutrophils
chemokine organism secreted by to attract reference
MIP-1α (CCL3) murine neutrophils DCs, MΦ [13][14], [15]
MIP-1β (CCL4) murine neutrophils DCs, MΦ [15]
MIG (CXCL9) murine neutrophils and MΦ T-cells [16]
IP-10 (CXCL10) murine neutrophils and MΦ T-cells [16]
1.1.3 Phagocytosis and production of reactive oxygen species
Besides the recruitment of immune cells, neutrophils themselves fight against invading
pathogens, which they recognize via pathogen associated molecular patterns (PAMPs).
Therefore neutrophils express pattern recognition receptors (PRR) such as Fcγ and c-type
lectin receptors. These receptors enclose pathogens within a vacuole in the neutrophil,
called phagosome. Their granules contain hydrolytic enzymes and Nicotinamide adenine
dinucleotide phosphate (NADPH) oxidase subunits, which are able to kill the pathogens
[18]. In detail, molecular oxygen is reduced by NADPH oxidase to superoxids, which
can form intermediates like hydrogen peroxide or hydroxyl radicals [19]. An advantage of
neutrophil phagocytosis in comparison to MΦ is the high speed uptake. Thus, Segal et al.
could show that immunoglobulin G (IgG) opsonized particle uptake and vacuole closure
in human neutrophils can be completed within 20 seconds [20]. Nevertheless a drawback
of this fast process is an incomplete phagosomal maturation, which releases ROS outside
of the neutrophil, which might result in damage of the surrounding tissue.
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1.2 The pathogen - Helicobacter pylori
Helicobacter pylori is a pathogen that effectively manages to prevent its elimination by the
host immune system. The Gram-negative bacterium is visually characterized by its spiral
shape and its six to eight flagella, which enable a strong motility of the bacteria. This
is essential for the pathogen, which exists in microaerophilic conditions and is exclusively
able to permanently colonize the human stomach. Originally H. pylori, formerly known
as Campylobacter pylori, was discovered and verified as pathogen by Barry Marshall and
Robin Warren in an experiment conducted on themselves in 1982. They could show that
the bacterium was the trigger for the inflammation of the stomach. For their discovery,
both researchers received the Nobel Price in Physiology and Medicine in 2005.
Computer simulations on DNA of a large number of H. pylori strains have indicated that
already 58.000 years ago the human stomach was colonized by H. pylori [21]. At that
time, people emigrated from Africa to Europe. Even today, the infection rate in many
African countries is still high at 80-90% of the population. However, in more industrialized
countries only 20-40% of the population is infected with H. pylori [22]. DNA sequenc-
ing data of the bacterial genome revealed that every person holds its own individual H.
pylori strain, because of its very high mutation rate [23]. This is facilitated by the fact
that the pathogen is naturally competent and can absorb and actively take up DNA from
the environment (natural competence of DNA transformation). Within families, the H.
pylori strains are highly genetically similar. This might be due to the fact that H. pylori
is probably efficiently transmitted by the oral-oral or fecal-oral route [24]. Usually a H.
pylori infection already happens in childhood within families, probably by a transfer of
the bacteria from the mother to the child [25], [26].
1.2.1 Clinical manifestation and treatment
Overall 50% of the world population is infected with H. pylori. An infection with H. pylori
can be detected by a urease-breath test, by H. pylori-specific antibodies in the blood, a
stool sample and/or by endoscopy and culture of the bacteria. After an acute H. pylori
infection, almost all people develop gastritis [27]. Depending on the H. pylori strain the
infection often results in an asymptomatic gastritis (80-90% of the infected persons) [28].
In up to 25% the infection results in a chronic atropic gastritis and stomach ulceration
[28]. Furthermore, infected individuals may rarely develop mucus associated lymphoid
tissue (MALT) lymphoma or even gastric cancer [28]. For this reason the International
Agency for Cancer Research (IARC) of the World Health Organization (WHO) classified
H. pylori as a class I carcinogen [29]. Until now, no protective vaccination against H.
pylori is available. However, an infection with H. pylori can be treated with antibiotics.
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Bacteria can be eradicated with a triple or quadruple therapy consisting of two or three
antibiotics in combination with an acid secretion inhibitor (proton pump inhibitor) after
testing for antibiotic resistance of the bacteria.
1.2.2 Colonization of the human stomach by H. pylori
The stomach mucosa is the habitat of H. pylori. This human organ is characterized by its
acidic pH, which increases from the lumen of the stomach in direction of the mucus layer
to the surface of the epithelial cells. H. pylori is able to produce ammonium catalyzed
by urease mediated cleavage of urea to neutralize the low gastric pH and to reduce the
viscosity of the mucus to protect itself against the gastric acid [30]. Furthermore, the
bacterium is able to orientate itself by chemotaxis within the pH gradient in the mucus
layer [31], [32]. The bacteria move with their flagella from the lumen into the mucus
layer. There the neutral pH protects the bacteria against the gastric acid [31]. Eaton
et al. could show that the flagella are essential for gastric colonization of H. pylori [33].
After penetrating of the protective mucus layer, H. pylori binds to stomach epithelial
cells. Therefore, the bacterium owns a set of different H. pylori outer membrane proteins
(HOPs). They enable binding to epithelial cells, mucus and immune cells and, as a result,
allow persistence of the bacteria. The best characterized and most important adhesins
are: HopQ, (which will be described in section 1.4.6) [34], [35], the blood group antigen
adhesin (BabA) [36] and the sialyl-Lewis x (sLex) adhesin SabA [37]. HopQ, BabA and
SabA all cluster together and share up to 35% genetic similarity [38]. BabA enables bind-
ing to fucosylated Lewis B receptors on epithelial cells as well as on mucus glycoproteins
such as MUC5AC [36], [39]. SabA mediates binding to sLex in membrane glycolipids and
can be switched off by phase variation [40] to escape a contact with cells in a vigorous
host defense [37]. Moreover, binding via SabA induces ROS production and phagocytosis
[41]. Thus, SabA is actively involved in neutrophil recruitment and activation. Besides
these outer membrane proteins (OMPs), H. pylori possesses further OMPS, but, for most
of them the function as well as the respective receptor are not known.
1.2.3 CagA - The oncoprotein of H. pylori
The cytotoxin associated gene A (CagA) of H. pylori is considered to be responsible for
a symptomatic progression of a H. pylori infection, besides other virulence factors and
host specific factors, such as genetic predispositions. The oncoprotein CagA has a size
of 120-145 kDa and is located on the cytotoxin associated pathogenicity island (Cag-
PAI). H. pylori strains carrying the Cag-PAI with a size of 40 kb, called type I strains,
are more virulent, whereas strains without the Cag-PAI were classified as type II strains
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[42]. In addition to the main virulence factor CagA, the Cag-PAI contains 27-31 other
genes, which form the type IV secretion system (T4SS) apparatus [43]. This needle-
like structure encompasses the inner and outer bacterial membrane as well as the host
membrane. Thereby, the T4SS enables H. pylori to translocate the only known effector
protein CagA into host cells [44]. In the C-terminal region of CagA one or more EPIYA
(Glu-Pro-Ile-Tyr-Ala) motifs can be found. These EPIYA motifs show variations in the
surrounding amino acids and can be classified as EPIYA A-D. Inside the host cell CagA
is phosphorylated on these EPIYA motifs by Src and c-Abl family kinases of the infected
cell (see Fig. 1.3, A) [45], [46].
The phosphorylation of CagA is pivotal for triggering disease, as it could be shown by
Ohnishi et al.. To prove the relevance of CagA phosphorylation, Ohnishi et al. gener-
ated transgenic mice expressing wt CagA and mice expressing a phosphorylation deficient
CagA. Mice expressing a phosphorylation deficient CagA did not develop leukocytosis,
myeloid leukemia, B-cell lymphoma and hematological malignancies, but mice expressing
wt CagA suffered from such disease [47]. This proves the importance of the CagA phos-
phorylation for the carcinogenicity of H. pylori.
After phosphorylation CagA can interact with several different cellular proteins (see Fig.
1.3, A), which influences various signaling cascades in the host cell, leading to cytoskele-
ton rearrangements, disruption of cell junctions as well as changes in proliferation and
the proinflammatory response [48].
c-Abl
Src
CagA
H. pylori
disruption of tight junctions, loss of cell polarity
Phosphorylated 
CagA
CagA
EPIYA
P
inflammationSHP-2
SHP-1
CagA
Non phosphorylated
CagA
Grb2
c-Met
A
B
E-cadherin
Ras-Raf-Mek-Erk
cell scattering
destabilization of adherens junctions
Ras-GAP
Csk
MARK2
TAK1 activation of NF-κB 
gastric
cells
Crk
PI3K
cell motility and elongation
Fig. 1.3: The effect of CagA on host cells
Schematic view on the interaction of phosphorylated CagA (A) and non phosphorylated CagA (B) with
several cellular proteins and their known consequences (arrow), (red line = inhibition). Modified from
[48], [49]
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The Src homology 2 (SH2) domain-containing protein 2 (SHP-2) was the first known pro-
tein to interact with phosphorylated CagA [50], [48]. Interaction of phosphorylated CagA
with SHP-2 leads to cytoskeleton rearrangements and increased cell motility as well as
cell elongation, forming the so called hummingbird phenotype of H. pylori infected cells
[49], because of an inhibition of the focal adhesion kinase (FAK) [51]. Furthermore, the
interaction of phosphorylated CagA with SHP-2 activates the RAS-Raf-Mek-Erk signal-
ing pathway. However, binding of phosphorylated CagA to the Ras GTPase activating
protein (Ras-GAP) can inhibit the activation of the pathway. In addition, binding of
phosphorylated CagA to the C-terminal Src kinase (Csk) can inhibit the CagA SHP-2
interaction. Moreover, this interaction inactivates Src kinase activity, which results in
a transient dephosphorylation of CagA. Nevertheless, CagA remains phosphorylated be-
cause of c-Abl takes over from Src and phosphorylates CagA [51]. In contrary to the
activation of SHP-2 enhancing the oncogenic activity of CagA, Src homology 2 (SH2)
domain-containing protein 1 (SHP-1) is able to dephosphorylate CagA and dampen its
carcinogenic action in a H. pylori infection [52], as well as SHP-1 down regulates signals in
hematopoietic and epithelial cells [53]. In addition, the phosphoinositide-3 (PI3)-kinase
(PI3K) and Crk interact with phosphorylated CagA resulting in cell motility and elonga-
tion. The complex of the growth factor receptor-bound protein (Grb)2 and CagA activates
Erk kinase signaling pathway and facilitates cell growth and cell scattering [54].
However, Grb2 also interacts with non phosphorylated CagA (see Fig. 1.3, B) resulting in
cell scattering, as well as the binding of CagA to the tyrosine kinase c-Met, which binds
to the hepatocyte growth factor and causes cell and massive tumor growth [55].
Destabilization also occurs when CagA interacts with E-cadherin and destabilizes E-
cadherin-ß-catenin complexes. Furthermore, the phosphorylation independent interaction
of CagA with the microtubule affinity-regulating kinase 2 (MARK2) inhibits their activity
and leads to disruption of tight junctions, loss of cell polarity and inhibits cellular prolif-
eration. Apart from that infected cells might undergo apoptosis and do not differentiate
anymore [56]. Moreover, CagA interacts with the host protein transforming growth factor-
β-activated kinase (TAK) 1, which is essential for the induction of NF-κB activation [57].
In addition to these interactions by CagA, which destroy the epithelial layer in particu-
lar, the injection of CagA via the T4SS results in release of proinflammatory chemokines
such as IL-8, which attracts neutrophils [6], [7], [8]. Neutrophils release MIP-1α and β
attracting MΦ and DCs [13], [14], [15]. Those in turn also secrete chemokines recruiting
B- and T-cells and activate the adaptive immune response (see section 1.3)
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1.3 Immune response to H. pylori
The H. pylori infection is characterized by a high density of bacteria in the human stomach
as well as its persistence and ongoing inflammation for years and decades. This suggests
that the immune system is dysregulated and not able to eliminate H. pylori. An infection
with the bacterium causes an inflammatory response as it was demonstrated by a mas-
sive neutrophil infiltration and the detection of proinflammatory cytokines such as IL-1β,
IL-6, IL-8 and TNFα in short term in vitro culture of biopsy samples of infected patients
[58], [59]. However, the activation of immune cells does not remove the bacteria, instead
the immune cells are manipulated by the bacteria resulting in damage and inflammation
[60], [61], [62], [63].
It starts with a deficient recognition of the bacterium by the immune system. H. pylori
makes use of modified PAMPs, which are not recognized by the immune system. Usu-
ally PAMPs such as LPS or flagella activate signal pathways via receptors like the toll
like receptors (TLR) on epithelial cells, as well as on neutrophils. A dephosphorylation
in the A domain of LPS of H. pylori results in a 1000-fold weaker activity compared to
LPS of Escherichia coli [64], [65]. Therefore, the activation of TLR4 and the subsequent
signaling cascades are weaker, too. Furthermore, other TLRs such as TLR5 are not able
to recognize the flagella of H. pylori, because of a mutation in the N-terminal D1 domain
of flagellin [66]. As a result the bacterium cannot be eliminated. Flagellin and the associ-
ated bacterial flagellar motility are required to establish and maintain colonization in the
stomach [67].
On the epithelial surface the bacterium injects its oncoprotein CagA into gastric epithe-
lial cells activating signaling cascades and resulting in inflammation (see section 1.2.3).
In addition, injection via the T4SS activates epithelial cells to release proinflammatory
chemokines such as IL-8. Thereby immune cells are recruited to the site of infection (see
Fig. 1.4) [68].
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Fig. 1.4: Chemokine secretion after CagA injection
In the stomach H. pylori moves into the mucus layer and translocates its oncoprotein CagA into epitheial
cells. Thus, the epithelial barrier may break open and H. pylori may enter the submucosa. As response
to CagA translocation via the T4SS, epithelial cells secrete chemokines such as IL-8, thereby recruiting
neutrophils. They release KC, MIP-1α, MIP-1β attracting MΦ and DCs. Those in turn secrete KC,
MCP-1 and IP-10 to recruit T-cells and thus activate the adaptive immune response. Modified from [69]
H. pylori invade gastric epithelial cells and has direct contact to immune cells in the lam-
ina propria [70]. Its interaction with PMNs, MΦ, DCs and T-cells is described in the
following sections.
1.3.1 Massive recruitment of neutrophils
Neutrophils are the first cells recruited to the site of infection to initiate pathogen elim-
ination. The massive recruitment of neutrophils is a hallmark of a H. pylori infection.
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Neutrophils phagocytose pathogens and produce ROS. However, Allen et al. could show
that H. pylori is able to disrupt NADPH oxidase activity leading to a strong extracellular
oxidative burst and evading of killing [60]. In addition, Ramarao et al. demonstrated that
H. pylori possesses an active antiphagocytic activity involving de novo protein synthesis
by the bacterium and the T4SS [71]. The bacterium itself supports neutrophil recruit-
ment and ROS production by activation of NADPH oxidase by secretion of H. pylori
neutrophil activation protein (HP-NAP) [72] and SabA [41]. The massive infiltration of
neutrophils results in tissue damage going along with a high number of apoptotic cells.
One benefit for H. pylori is the release of nutrients from these apoptotic cells [69]. Apart
from phagocytosis and ROS production, neutrophils secrete chemokines such as MIP-1α
and β (see section 1.1.2) to recruit further immune cells like MΦ and DCs to the site of
infection (see Fig. 1.4).
1.3.2 Manipulation of macrophages and DCs
MΦ and DCs secrete KC to attract further neutrophils and the monocyte chemoattrac-
tant protein 1 (MCP-1/CCL2) to recruit more MΦ (see Fig. 1.4).
The main task of MΦ and DCs is phagocytosis of invading pathogens. Arnold et al.
could show that CXCR1 postive MΦ and CD11b positive DCs are mainly responsible
for phagocytosis of H. pylori [73]. However, Allen et al. demonstrated that phagosoms
of MΦ infected with H. pylori strains fused and formed so-called megasomes containing
live bacteria [61]. Furthermore, the bacterium can interfere with phagocytosis by MΦ
involving bacterial de novo protein synthesis and the T4SS [71]. Moreover, H. pylori ex-
presses an arginase enzyme inhibiting the nitric oxid (NO) production by activated MΦ
and consequently preventing NO mediated killing of the bacterium [74]. Furthermore, H.
pylori induces apoptosis of MΦ by activation of arginase II [75]. Apoptosis of MΦ recruits
further PMNs.
DCs and MΦ are divided in immature and mature cells. After phagocytosis immature
cells process phagocytosed antigens and present them on their surface. This results in
maturation of the cells. It could be shown that the direct binding of neutrophils to DCs
promotes their maturation and provides DCs access to phagocytosed pathogen products
[18], [76], [77]. Once maturated, DCs and MΦ are able to interact with CD4 positive
T-cells and B-cells and initiate the adaptive immune response.
H. pylori is able to manipulate the maturation of DCs resulting in semimature DCs, which
process antigens of pathogens, but do not present them to TLRs. These semimature DCs
are called tolerogenic DCs and can initiate the differentiation of naive T-cells to regula-
tory T-cells with suppressed activity [78].
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1.3.3 Downregulation of the adaptive immune response by T-
cells
T-cells are recruited by MΦ and DCs via the secretion of IP-10 (see section 1.1.2 and
Fig. 1.4). After activation CD4 positive T-cells can differentiate in T helper cells type
1 or type 2. T-cells isolated from infected gastric mucosa secrete high levels of IFNγ,
indicating a T helper cell type 1 response [79]. This response is initiated by H. pylori.
The bacterium stimulates via HP-NAP the production of IL-12 from DCs and MΦ as well
as IL-23 from neutrophils. The release of IL-12 stimulates T helper cells type 1 to secrete
IFNγ [80], which is linked to the development of peptic ulcers [63] and contributes to
T-cell polarization [81]. The T helper cell type 1 immune response induced by H. pylori
is a further explanation for the ineffectiveness to remove the bacterium.
Another important virulence factor of H. pylori is the vacuolating cytotoxin A (VacA).
The main function of VacA is the induction of apoptosis, resulting in elimination of im-
mune cells and release of nutrients [82]. Therefore, VacA binds to the cell surface and
forms an anion selective channel in the endosome membrane. By osmotic swelling these
channels transform to a vacuole [83]. The intoxication with VacA down regulates the IL-2
production. Thus, the viability and proliferation of T-cells [62] and thereby the adaptive
immune response are influenced in a negative way.
All these examples show that the bacterium manipulates the host immune system and
thereby prevents its elimination. An additional reason for the persistence of H. pylori in
the stomach is its extreme adaptability to the host. H. pylori strains have a very high
genetic variability, so that every infected person has its own genetically distinct H. pylori
strain [23]. For this, membrane proteins enabling interaction with host cells play a key
role. Important membrane proteins of epithelial cells and neutrophils, which function as
pathogen receptors and initiate activating or inhibiting signaling pathways, are the so
called CEACAMs.
1.4 CEACAMs
The carcino-embryonic antigen (CEA) was initially discovered in 1965 by Gold and Freed-
man and was also described in 1969 independently by Kleist and Burtin. Both described
a new family of antigens, which only exists in colonic tumors, fetal gut, liver and pancreas
[84], [85], [86]. At that time CEA expression could not be detected in healthy colonic mu-
cosa. Later in 1989 Boucher et al. could show that CEA is expressed in healthy mucosa,
too. However, there the expression was much lower [87]. In 1988, Thompson et al. iden-
tified CEA releated genes and analyzed their sequences by cloning. This group localized
CEA related genes on the human chromosome 19 in the region 19q13.1-3. and assigned
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them to the immunoglobulin super family [88], [89]. On the basis of their sequence sim-
ilarity they divided the CEA family in two groups: One consists of the classical CEA
antigens and the other included the pregnancy-specific glycoproteins (PSG) [88]. This
definition was confirmed by 26 CEACAM research groups in a workshop in Colorado in
1997. From then on, the classical CEA antigens were called CEA related cell adhesion
molecules (CEACAMs) [90].
1.4.1 Structure and function of CEACAMs
Structural analysis revealed that CEACAMs are composed of several immunoglobulin
like domains [89]. Many human CEACAMs consist of a N-terminal domain with 108-
110 amino acids, whose secondary structure forms an immunoglobulin variable domain
(IgV) following a variable number of immunoglobulin constant domains (IgC) (see sec-
tions 1.4.2-4 and Fig. 1.5 for details) [88].
human 
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Fig. 1.5: Structure of human CEACAM1, 3 and 6 on neutrophils
Human neutrophils express CEACAM1, 3 and 6. CEACAM1 and 6 consist of several immunoglobulin
like constant domains (IgC) (blue), followed by one immunoglobulin variable domain (IgV) (red), while
CEACAM3 lacks the IgC domain. CEACAM1 and 3 own a transmembrane domain (purple), whereas
CEACAM6 is anchored to the membrane by a glycosyl-phosphatidyl-inositol (GPI) anchor (green). Fur-
thermore, human CEACAM1 possesses two ITIMs and human CEACAM3 has an ITAM. Modified from
[91].
Today, twelve different CEACAMs are known [92]. They are highly conserved and can
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be found so far in 27 mammals [93]. Beside different PSGs, humans harbour CEACAM
1, 3-8, 16 and 18-21. Whereas, in mice Kammerer et al. found only murine CEACAM1,
2 and 9-20 as well as different PSGs [93]. In general, the CEACAM tissue expression
is very broadly distributed. Thus, CEACAMs are expressed on immune cells as well as
epithelial cells of the gastrointestinal tract, the lung, the nasopharynx, the sweat and the
urogenital tract [94], [95]. The IgV domain of CEACAMs functions as a pathogen receptor
for cell adhesion of different Gram negative human pathogens, all colonizing the mucus
layer, such as E. coli, Haemophilus influenzae, H. pylori, Neisseria gonorrhoeae, Neisseria
meningitidis, Moraxella catarrhalis and different Salmonella strains [96], [97], [34], [98],
[99]. Furthermore, in 2017 it was shown that CEACAM1, 3, 5 and 6 act as a receptor for
the human pathogenic fungi Candida albicans and Candida glabrata via the N-terminal
IgV domain [100]. Besides their function as pathogen receptors CEACAMs promote inter-
and intracellular signaling [101], [102]. Moreover, the small glycoproteins influence the tis-
sue architecture, differentiation and cell death, as described for CEACAM6 [103], as well
as the insulin metabolism [104] and the neovascularization as described for CEACAM1
[105]. In medical science CEACAMs, especially CEACAM6, which is over-expressed in
tumor tissue, function as important biomarkers and are promising therapeutics for cancer
treatment.
In the following part CEACAMs that are important for this work, human CEACAM1, 3
and 6 on neutrophils, that are able to interact with H. pylori, are further characterized.
Moreover, the two murine variants of human CEACAM1, murine CEACAM1 and 2 are
discussed.
1.4.2 Human CEACAM1
Human CEACAM1, also called CD66a, is expressed almost in all cell types, e. g. on
epithelial-, endothelial, lymphoid and myeloid cells [106]. It consists of three IgC do-
mains (see Fig. 1.5, blue), one IgV like domain (red) and a transmembrane domain
(purple). Because of alternative splicing of the primary mRNA, several different isoforms
of CEACAM1 occur, some of them with a cytoplasmic tail have two Immunoreceptor
tyrosine-based inhibitory motifs (ITIMs) [107], characterized by the following sequence
(I/L/V/S)xYxx(L/V) [93]. In general, CEACAM1 can exist as a monomer or a dimer.
It interacts with other CEACAMs or homodimerizes with CEACAM1 molecules via the
N-terminal part of the IgV domain [108]. This is important for the communication with
immune cells. In its dimerized form, the receptor can recruit SHP-1 via its ITIMs, which
are phosphorylated by Src kinases [109]. Thereby, inhibitory signals are mediated, which
limit the immune response. This mechanism is exploited by bacterial species such as
Neisseria or Moraxella. Binding of N. gonorrhoeae to CEACAM1 leads to inhibition of
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the CD4+ T-cell response via the ITIM. Furthermore, the B-cell response is suppressed
as well [101]. In addition, M. catarrhalis and N. meningitidis bypass the immune response
by binding to CEACAM1 on bronchial epithelial cells, whereby the ITIM-mediated inhi-
bition of the TLR2 activated transcription factor NF-κB prevents an adequate immune
response [102]. Whether pathogens also inhibit the immune response through CEACAM1
on neutrophils is so far unknown. In general, Singer et al. could show that CEACAM1
delays apoptosis in rat granulocytes, thereby resulting in longer survival [110]. Especially
for neutrophils it could be shown that CEACAM1 supports the bacterial internaliza-
tion depending on the phosphatidylinositol-3‘kinase (PI3K) [111]. But, overexpression
of CEACAM1 IgC2 domains stops CEACAM1 mediated internalization [111]. Moreover,
CEACAM1 is partly responsible for granulopoiesis of neutrophils [112] and in combina-
tion with CEACAM3 and 6 CEACAM1 boost the neutrophil response against Neisseria
[113].
1.4.3 Human CEACAM3
Human CEACAM3 (CD66d) is exclusively expressed on human granulocytes [114], [115].
It consists of one IgV like domain (see Fig. 1.5, red) and one transmembrane domain
(purple). The cytoplasmic tail of CEACAM3 consists of an ITAM like motif (see Fig.
1.5), (YXXL/Ix6-8YXXL/I), that gets phosphorylated by Src kinase, inducing activating
signals. This stimulates the small GTPase Rac, which is responsible for actin cytoskeleton
dynamics and the production of ROS [116]. Sarantis et al. could show that the ITAM of
CEACAM3 is responsible for neutrophil activation, ROS production and degranulation
of cells infected with Neisseria [113]. Furthermore, the interaction of N. gonorrhoeae,
N. meningitidis, M. catarrhalis or H. influenzae with CEACAM3 leads to opsonin inde-
pendent phagocytosis [116]. This process is ITAM independent [113] and compared to
CEACAM1 induces phagocytosis much more efficiently [116]. Moreover, the phagocytosis
is independent of PI3K, however, it is essential for ROS production [117]. Compared to
other CEACAMs, CEACAM3 does not interact with itself or other CEACAMs. Further-
more, coexpression of CEACAM3 with the inhibitory CEACAM1 does not result in an
inhibition of the immune response [113].
1.4.4 Human CEACAM6
Characteristic for the CEACAM6 molecule, consisting of two IgC (see Fig. 1.5 blue) and
one IgV like domain (red), is the fixation via a GPI anchor (green) to the plasma mem-
brane. Only primates own CEACAMs with a GPI anchor [93]. CEACAM6 is expressed
on human neutrophils and different epithelial cells, for example in stomach epithelial cells
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[95]. Moreover, soluble CEACAM6 was detected in the blood. CEACAM6 acts as an
important marker in medical science and diagnostics, because it is overexpressed in tu-
mors [95], which led to its discovery. Furthermore, CEACAM6 is held responsible for
the development of tumors, because the overexpression of CEACAM6 destroys the tissue
architecture, blocks differentiation and induction of the programmed cell death (anoikis)
[103]. All these functions depend on the GPI anchor of CEACAM6 [118], which has
probably developed by changes in the transmembrane domain of CEACAM1 [119]. The
transmembrane domain of CEACAM1 has a contrary inhibitory anti tumorgenic effect as
compared to CEACAM6. Like CEACAM1, CEACAM6 supports bacterial internalization
[111] and interacts with itself (homophilic interaction) as well as with other CEACAMs
(heterophilic interaction). The exact function of CEACAM6 on neutrophils and its role
in the interaction with pathogens is so far unknown.
1.4.5 Murine CEACAM1 and 2
In contrast to humans, mice express two different variants of CEACAM1: murine CEA-
CAM1 (formerly called as biliary glycoprotein (Bgp)1) and murine CEACAM2 (Bgp2).
Both are located on murine chromosome seven and share conserved exon and intron
structures [120], [121] and have a sequence structure similarity of 79,6 % [122]. However,
Robitaille et al. could show that murine CEACAM1 and 2 produce different splice vari-
ants, which differ in their gene expression pattern and therefore in their function [123].
Murine CEACAM1 is expressed during embryonal development and in the adult organ-
ism in different tissues, such as: the liver, the small intestine, the prostate and the spleen
[122]. However, murine CEACAM2 is expressed in the crypts of epithelial- and intestine
tissue, in the kidney, in the uterus, in gut-resident MΦs [123], in the liver, the brain [120],
in the testicle, in the spleen (low expression) [122] and on murine blood platelets [124]. On
granulocytes murine CEACAM1 was detected, but not murine CEACAM2 [123]. The dif-
ferent functions of murine CEACAM1 and 2 were analyzed in aggregation experiments: It
could be shown that only murine CEACAM1 functions as a homophilic binding molecule
[123]. All in all, murine CEACAM1 is more similar to human CEACAM1 in compari-
son to murine CEACAM2 [122]. However, the differences in the sequence of human and
murine CEACAM1 are considered to be sufficient to cause different functions, as it is
exemplified by the fact that murine CEACAM1 does not support bacterial internalization
[125]. Moreover, murine CEACAM1 does not function as a receptor for human pathogens
like H. pylori and Neisseria [34], [126]. Another difference between human and murine
CEACAM1 is the immunorezeptor tyrosine based switch motif (ITSM), TxYxx(V/I),
which characterizes murine CEACAM1 besides its ITIM. Similar to the ITIM, SHP1 and
SHP2 bind to the ITSM after phosphorylation by Src kinase. The difference between
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the ITIM and the ITSM is the necessity of an adapter molecule bound by the ITSM.
Then, depending on the adapter molecule the ITSM gets phosphorylated or dephospho-
rylated and results in activating or inhibitory signals. Evolutionary speaking, CEACAM1
of Catarrhini apes (also called as old world monkeys), including humans, in former times
also possessed an ITSM. This ITSM was replaced by the second ITIM in CEACAM1 of
Homo sapiens [93]. An other model organism in H. pylori research the Mongolian gerbil
(Meriones unguiculatus) (see section 1.5) which also contains an ITSM in its CEACAM1.
Thus, it would be interesting to know more about the Mongolian gerbil CEACAMs, espe-
cially their CEACAM1, since little is known about CEACAM1 in Mongolian Gerbils so far.
1.4.6 H. pylori - CEACAM interaction
H. pylori recognizes human CEACAM1, 3, 5 and 6 via the IgV like N-terminal domain
[34]. For this the bacterium uses HopQ, which was identified to be the main and so far
only known binding adhesin of H. pylori for CEACAMs [34], [35]. In other bacteria such
as Neisseria several different opacity proteins (Opa) proteins interact with CEACAMs.
Moreover, Opa proteins are phase-variable. Although, H. pylori is able to turn off SabA,
the bacterium cannot switch off HopQ. The protein exists in two forms HopQI and HopQII
[127]. Some studies have linked the occurrence of HopQI and the oncoprotein CagA of H.
pylori and demonstrated a stronger binding and CagA phosphorylation in HopQI strains
[127]. HopQ interacts with human CEACAMs via the interface between two CEACAM
molecules and inhibits CEACAM dimerization [38]. However, murine, bovine and canine
CEACAMs are not recognized by HopQ [34]. An explanation could be the high adaptabil-
ity to humans and the differences in CEACAMs in different species. In murine neutrophils
only murine CEACAM1 is expressed, whereas in human neutrophils CEACAM1, 3 and 6
were detected. Human CEACAMs function as pathogen receptors for H. pylori and are
essential for CagA translocation [128]. No other functions of CEACAMs in the interaction
with H. pylori are known so far.
20
1. INTRODUCTION
1.5 H. pylori infection model systems
Besides in vitro infection experiments and analysis of biopsy-derived tissues, also in vivo
infection experiments are performed in research on H. pylori. For these, the most common
model organism in infection research is Mus musculus. But, human clinical isolates of H.
pylori do not colonize mice [129]. Only a few mouse adapted strains, such as the Sydney
strain (SS1), were successfully isolated from the murine stomach after experimental infec-
tions [130]. Colonization of C57BL6 mice with the SS1 strain resulted after six month in
an active chronic gastritis [130]. In comparison to humans, the mouse adapted H. pylori
strain only cause a mild pathology in mice. Thus, the mouse is a not suitable animal
model to study a H. pylori induced gastric pathology.
In 1996, Hirayama et al. could show that H. pylori colonize in Mongolian gerbils (Meri-
ones unguiculatus) and cause an infiltration of PMNs and mononuclear cells in the mucus
layer of the gastric epithelium indicating a gastritis [131]. Other researcher confirmed
these results and demonstrated the development of intestinal metaplasia, gastric ulcer
[132] and after 18 month of infection gastric cancer [133]. Moreover, Matsumoto et al.
showed that it is possible to clear the infection by an eradication of the bacterium by
antibiotic therapy using amoxycillin [134]. Thus, the pathology of an infection of the
Mongolian gerbil with H. pylori is more comparable to the human situation [135]. How-
ever, Mongolian gerbils are not an ideal model organism, because nearly no antibodies or
transgenic animals are available. In addition, the genome of the Mongolian gerbil is only
known since 2019 [136]. In order to establish a better model system, different humanized
mouse lines are now being investigated.
A possible model system for H. pylori research could be humanized CEACAM mice.
Originally, Eades et al. generated transgenic CEA mice expressing human CEACAM5 to
establish an animal model for tumor immunotherapy, because CEACAMs were overex-
pressed in tumor tissue [137]. Ten years later, Chan et al. transferred a CEA bacterial
artifical chromosome (CEABAC) in mice, which consists of the complete genes for human
CEACAM3, 5, 6 and 7 [138]. Their aim was to perform preclinical testing of CEA-
targeted therapies as well as studies with N. gonorrhoeae, which interacts with CEACAM
receptors [138]. In addition, Gu et al. established a transgenic mouse expressing hu-
man CEACAM1, named tg418, to study the interaction of human pathogens with human
CEACAM1 [126]. Furthermore, Gray-Owen and his team combined both mouse lines and
generated a mouse expressing human CEACAM1, 3, 5, 6 and 7 (unpublished).
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1.6 Aims of this work
H. pylori, classified by the WHO as a class I carcinogen, persistently colonizes the stom-
ach of half of the worlds population. Characteristic of a H. pylori infection is a massive
infiltration of neutrophils, which are the first recruited immune cells getting in touch with
the bacterium. Their task is to initiate the removal of invading pathogens, but the innate
immune cells and the following immune response are apparently successfully manipulated
by H. pylori and not able to eliminate the bacterium. The massive production of ROS of
the PMNs destroys the surrounding tissue, but not the bacteria. In humans the ongoing
infection can result in various magliancies such as gastric cancer, whereas mice infected
with H. pylori show only a mild pathology. Humans express several CEACAMs on the
surface of different cell types. They function as pathogen receptors and promote intra- and
intercellular signaling, such as human CEACAM1 expressed on B- and T-cells inhibiting
the immune response and CEACAM6 promoting the development of tumors [101], [103].
Moreover, CEACAM3, which is exclusively expressed on granulocytes, enhance ROS pro-
duction and promote phagocytosis of human pathogens such as N. gonorrhoeae [116]. For
H. pylori human CEACAMs are essential to translocate CagA into gastric epithelial cells
[128]. However, their role on neutrophils has not been investigated so far. On human
neutrophils CEACAM1, 3 and 6 are expressed. Previous work demonstrated the interac-
tion of H. pylori with human CEACAM1, 5 and 6 [34]. In contrast, murine neutrophils
express only murine CEACAM1, which does not function as a receptor for H. pylori [34].
The aim of this work was to study the role of human CEACAMs for the interaction
of H. pylori with neutrophils. Thus, migration, ROS production, binding, phagocytosis,
chemokine secretion and CagA translocation and phosphorylation were studied in human,
murine and humanized CEACAM neutrophils, DCs and MΦ. Furthermore, neutrophils
of naive and chronically infected humans and mice have been investigated. This might
facilitate the understanding of the host pathogen interaction. Moreover, it may lead to a
more suitable humanized mouse model to study the H. pylori infection in vivo.
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2. Material and methods
2.1 Isolation and cultivation of cells
2.1.1 Mouse lines
Tab. 2.1 lists all mouse lines used in this work.
Tab. 2.1: Overview of all mouse lines used in this work
name description reference
wt C57BL/6 mice
hCEACAM1 Human CEACAM1 transgenic mice [126]
cross breeded with C57BL/6 2D2
to eliminate murine CEACAM1
hCEACAM3, 6 Human CEACAM3, 5, 6, 7 transgenic [138]
mice cross breeded with C57BL/6 2D2
to eliminate murine CEACAM1
hCEACAM1, 3, 6 Human CEACAM1, 3, 5, 6, 7 transgenic kindly
mice cross breeded with C57BL/6 2D2 provided by
to eliminate murine CEACAM1 Prof. Gray Owen
All procedures with these specific-pathogen-free mice (see Tab. 2.1) were performed ac-
cording to the guidelines for care and use of laboratory animals by a veterinarian. They
were approved by the Regierung von Oberbayern (ROB-55.2-2532.Vet 02-18-189).
The humanized CEACAM mouse lines were kindly provided by Prof. Dr. John E. Shively,
Prof. Dr. Clifford Stanners and Prof. Gray Owen. All humanized CEACAM mouse lines
were crossed with the C57BL/6 2D2 mouse line. In this mouse line the murine CEACAM1
gene is inactive. Thus, negative effect of two different CEACAM1 versions in one mouse
can be avoided.
For infections two times a dose of 10 9 bacteria of the H. pylori strain PMSS1 (see Tab.
2.6) were injected orogastrically in mice. After four weeks the animals were killed with
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CO2. To prove the infection with H. pylori, stomach tissue was homogenized and colony
forming units (CFUs) of the bacteria were calculated.
2.1.2 Isolation of murine neutrophils
The isolation of murine bone marrow derived neutrophils from wt and different humanized
CEACAM mice (see Tab. 2.1) was performed according to the method of Schymeinsky
et al. by density gradient centrifugation [139], [140]. In detail, first the hind leg bones
(femur and tibia) of the mice were prepared. Then the intact bones were incubated in 70%
ethanol in a sterile Petri dish for a few min for disinfection. Both ends of the bones were
cut with a sterile scalpel, so that the bones could be flushed with a needle using phos-
phate buffered saline (PBS) without calcium and magnesium (Life Technologies). The cell
suspension resulting of flushing the bones was centrifuged. The obtained cell pellet was
resuspended and applied on a Percoll gradient consisting of 72%, 64% and 52% Percoll.
After 30 min centrifugation at 1000 x g at 4 ◦C without using brake different cell types
were separated by their density in the Percoll gradient. The cell layer between 64% and
72% Percoll was cultivated in RPMI 1640 cell culture medium supplemented with 10%
FCS (Life Technologies) and 20% supernatant of WEHI3B cells producing IL-3 overnight.
2.1.3 Isolation of human neutrophils
Human neutrophils were obtained from blood of healthy adult volunteers by density gradi-
ent centrifugation, as described before by [141]. All volunteers signed a written approve-
ment. The collection was conducted according to the Declaration of Helsinki and was
approved by the Ethics Committee of the LMU Munich. Briefly, 40 ml of human blood
was taken and heparinized with 10 U/ml. One fifth of the total volume was centrifuged
at 1000 x g for 5 min at room temperature (RT). The serum was added to the human
blood and incubated at RT to separate red from white blood cells. After 1.5 h the white
blood cells were layered on top of a Percoll gradient consisting of 4 ml 74% and 3 ml
55% Percoll (Sigma). The gradient was centrifuged at 600 x g for 20 min at RT without
a brake. Afterwards the human neutrophils were taken from the interphase between the
two Percoll layers and washed with PBS.
2.1.4 Isolation of murine DCs and MΦ
Murine DCs and MΦ were received from murine bone marrow after eight to twelve days
of differentiation in media with GM-CSF or M-CSF, according to the protocol of Lutz et.
al. [142]. In detail, the bone marrow was flushed with PBS from femur and tibia similar
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to the isolation of bone marrow-derived neutrophils (see section 2.1.2). Afterwards 5 x
10 6 cells of the murine bone marrow were cultivated in a petridish at 37 ◦C and 5% CO2
in RPMI 1640 supplemented with 20 ng/ml rm GM-CSF to differentiate to DCs and in
Dulbecco‘s Modified Eagle medium (DMEM) supplemented with 10 ng/ml rm M-CSF
to differentiate to MΦ (see Tab. 2.2). After three and seven days of cultivation new
media were added to the cells. DCs were harvested 8-10 days and MΦ 10-12 days after
stimulation.
Tab. 2.2: Medium of murine DCs and MΦ
cells medium company
DCs RPMI 1640 1640 with 2 mM L-glutamine Life Technologies
+ 10% FCS Life Technologies
+ 20 ng/ml rm GM-CSF PeperoTech
MΦ DMEM with 2 mM L-glutamine Life Technologies
+ 5% horse serum (heat inactivated) PAA
+ 10 mM HEPES Life Technologies
+ 1 mM pyruvate Life Technologies
+ 10 ng/ml rm M-CSF ImmunoTools
2.1.5 Isolation of human DCs and MΦ
Human monocytes were obtained from blood of healthy, adult volunteers according to
ethical guidelines (see section 2.1.3) and were differentiated to DCs and MΦ. Briefly, 20
ml blood were taken and heparinized (see section 2.1.3). The blood was mixed with 30
ml PBS and layered on 15 ml Ficoll. After 30 min centrifugation at 400 x g without
brake at RT monocytes were collected from the interphase. They were washed with PBS
and resuspended in 100 µl PBS. Then, 20 µl human CD14 MACS beads (Milteny Biotec)
were added, followed by 15 min incubation at 4 ◦C and a subsequent washing with PBS.
Afterwards cells bound to the MACS beads were isolated using the magnetic force in an
equilibrated MACS column. After three washing steps the cells were detached with me-
chanical force. They were washed again and were incubated in RPMI 1640 with 2% FCS,
50 ng/ml rh GM-CSF (ImmunoTools) and 1000 Units IL-4 for six days to differentiate to
DCs. MΦ were isolated according to the same protocol except media usage. MΦ media
contained 50 ng/ml rh M-CSF (ImmunoTools). Media were changed every two days.
25
2. MATERIAL AND METHODS
2.1.6 Cell lines and their cultivation
Tab. 2.3 lists all cell lines used in this work.
Tab. 2.3: Cell lines used in this work
cell line description reference
B16-GM-CSF murine melanoma cell line kindly
B16-F10 with retroviral vector provided by
for rm GM-CSF Ms. Anding
CHO-SCF immortalized cell line from kindly
hamster ovaries (CHO) provided by
transfected with SCF cDNA Ms. Anding
HM5 GM-CSF producing kindly
CHO cell line provided by
Prof. Gray Owen
Hoxb8 wt neutrophil cell line generated
neutrophils of murine bone marrow in this work
without murine of C57BL/6 2D2 mice
CEACAM1
Hoxb8 neutrophil cell line generated
CEACAM1, 3, 6 of murine bone marrow in this work
neutrophils of C57BL/6 2D2 tg418 CEABAC mice
MPRO murine bone marrow cell line ATCC
CRL 11422
MPRO CEACAM 1 murine bone marrow cell line [113]
expressing human CEACAM 1
MPRO CEACAM 3 murine bone marrow cell line [113]
expressing human CEACAM 3
Phoenix Eco human kidney cell line kindly
(packaging cell line) provided by
Ms. Anding
WEHI3B murine myelomonocyte leukemia, ACC 26
IL-3 producing cell line
Cells were cultivated at 37 ◦C and 5% CO2 in 75 cm
2 tissue culture flasks (BD Falcon) and
subcultured every 2-3 days. In detail, the adherent cell lines B16-GMCSF, CHO-SCF and
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HM5 were washed with PBS. Then 0.5% Trypsin/EDTA (Life Technologies) was added
and the cells were incubated for a few minutes at 37 ◦C and 5% CO2. After detachment
of the cells the reaction was stopped with media (see Tab. 2.4), and the cell suspension
was splitted 1:4 to 1:8 and supplemented with fresh media. WEHI3B cells were scraped
off with a cell scraper, splitted 1:3 and supplemented with fresh media (see Tab. 2.4).
The suspension cell lines Hoxb8 and MPRO cell lines were splitted 1:4 to 1:8 and new
media were added.
Tab. 2.4 lists all cell culture medium for cell lines used in this work.
Tab. 2.4: Cell culture medium used in this work
cell line medium company
B16-GMCSF RPMI 1640 Life Technologies
+ 10% FCS Life Technologies
CHO-SCF Opti-MEM GlutaMAX Life Technologies
+ 10% FCS Life Technologies
+ 3 µM ß-Mercaptoethanol Gibco
HM5 DMEM Life Technologies
+ 10% FCS Life Technologies
+ 1% GluatMAX Gibco
WEHI3B RPMI 1640 Life Technologies
+ 10% FCS Life Technologies
Hoxb8 Optimem Glutamax Life Technologies
+ 10% FCS Life Technologies
+ 0.06% ß-Mercaptoethanol Life Technologies
+ 1% supernatant of SCF cells
+ 0.01% ß-Estradiol Sigma
MPRO Isocov‘s modified Dulbeccos media (IMDM) Life Technologies
+ 20% horse serum (heat inactivated) PAA
+ 1.5 g/L sodium bicarbonat Sigma
+ 1% Gluatmax Gibco
+ 2.5% supernatant of HM5 cells
For determination of cell numbers the cells were counted with a Casy cell counter (OLS
OMNI Life Science). Apart from that cell numbers were calculated by a life/death stain-
ing using a Neubauer cell counting chamber. Then, defined cell numbers were seeded in
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cell culture plates and used for experiments.
2.1.7 Immortalization and differentiation of cells
Neutrophils, MΦ and DCs arise from a hematopoietic stem cell and have a limited life time.
In order to cultivate these cells they have to be immortalized. Before the experiments
immortalization is canceled by adding or removing medium components as described in
the following part and cells differentiate again. In detail, Hoxb8 cells were arrested by
ß-estradiol (Sigma) and differentiate in media without ß-estradiol. MPRO cells were im-
mortalized by a dominant negative retinoic acid receptor. After 72 h in medium with
a physiological dose of retinoic acid they start differentiation again. Differentiation of
isolated blood or bone marrow cells are described before (see section 2.1.2-5).
2.1.8 Cryoconservation of cells
For cryoconservation, a defined number of cells was centrifuged and resuspended in their
respective cell culture medium supplemented with 20% FCS and 10% DMSO (Sigma) in
cryogenic tubes (Nalgene, Thermo Fisher Scientific). Those tubes were stored for at least
24 h at −80 ◦C and then for long term storage, in liquid nitrogen at −196 ◦C.
For thawing of cells, the cryogenic tubes were incubated at 37 ◦C until the cells were
nearly completely thawed. Then cell culture medium was added and the cell suspension
was centrifuged. Afterwards the supernatant was discarded. The cell pellet was resus-
pended in cell culture medium and transferred to a 75 cm 2 tissue culture flask, which was
incubated at 37 ◦C as described in section 2.1.6.
2.1.9 Generation of ER-Hoxb8 neutrophil cell lines
Neutrophils isolated from the bone marrow have a short life time, their number is lim-
ited and their isolation is time consuming and expensive. Therefore, progenitor cells of
neutrophils were immortalized according to Wang et al. by retroviral transfection with
ER-Hoxb8. Thus, unlimited amounts of progenitor cells of this cell line can be cultured
and differentiated to neutrophils [143]. In detail, Wang et al. fused the estrogen binding
domain of an estrogen receptor (ER) to the N-terminus of Hoxb8. Then the fusion cDNA
was cloned in a retroviral vector [143], which was transfected in stimulated progenitor
cells. Estrogen added to the neutrophil cell culture media arrests the cells by binding to
the fusion product of the estrogen receptor and Hoxb8. Whereas in neutrophil cell culture
media without estrogen cells differentiate to neutrophils.
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In this work ER-Hoxb8 neutrophils were generated from C57BL/6 2D2 mice, which do not
express murine CEACAM1 anymore. In addition, ER-Hoxb8 neutrophils were generated
from C57BL/6 2D2 mice, expressing human CEACAM1, 3 and 6. Briefly, bone marrow
was isolated from femur and tibia. Afterwards cells were stimulated with 10 ng/ml murine
IL-3 (PeperoTech), 20 ng/ml murine IL6 (PeperoTech) and 1% SCF for two days. Mean-
while 19.4 µl of the vector and 10 µg DNA were transfected with 25 µl Lipofectamin2000
(Life Technologies) in 58.5 µl in pCLEco, Top 10 packing vector. This was transfected in
a Phoenix Eco packing cell line, thereby producing virus particles. After two days, the
prestimulated cells were infected with 3 ml virus containing supernatant. Then, 5 µg/µl
polybrene (Millipore) was added for a higher efficiency of gene transfer. Thus, the fusion
product of ER and Hoxb8 randomly integrate in the genome of the cells. By adding
SCF, gained from CHO cells, the cells develop to progenitor cells, which were arrested by
ß-estradiol in the cell culture media.
2.2 Microbiological methods
2.2.1 Bacterial strains
Tab. 2.5-2.6 show all bacterial strains used in this work.
Tab. 2.5: H. pylori strains used in this work part I
strain internal ID description reference
26695 VKH5 wildtype; clinical [144]
isolate
26695 ∆hopQ VKH18 ∆hopQ mutant of 26695 Odenbreit (not published)
G27 LHP20 wildtype; clinical [145]
isolate
G27 ∆hopQ VKH70 ∆hopQ mutant of G27 Königer (not published)
B8 EL5 gerbil adapted [146]
SS1 UB242 murine, passaged isolate [130]
of the clinical isolate
10700, the PMSS1
X47 UB24 mouse adapted [147]
PMSS1 UB47 clinical isolate, [148]
parental strain of SS1
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Tab. 2.6: H. pylori strains used in this work part II
(CmR: Chloramphenicol resistance, KanR: Kanamycin resistance, ErmR: Erythromycin resistance,
strepR/S: streptomycin sensitivity)
strain internal ID description reference
P12 WSP12 wildtype; clinical [149]
isolate (888-0) from the
University of Hamburg
P12 ∆cagI WSP556 P12 transformed with [150]
pWS320; ErmR;
∆cagI
P12 ∆hopQ WSP1254 P12 transformed with [38]
pFS10; ErmR;
∆hopQ
P12 ∆cagA PJP52 P12 transformed with [44]
pWS30; KanR;
∆cagA
P12 ∆vacA P163 clinical isolate lacking Fischer
vacA; ErmR
P12 ∆cagA∆vacA P165 P12 ∆vacA (P163), Haas
ErmR, transformed with (not published)
pWS130
P12 strep wt GFP LH-P229 pHel4-GFP [34]
P12 strep ∆hopQ GFP LH-P230 ∆hopQ; pHel4-GFP [34]
P12 TEM-CagA FSP1 P12[pWS373] transformed [151]
with pWS486; CmR;
expressing TEM-CagA
P12 TEM-CagA; ∆cagI FSP2 P12[pWS486] transformed [151]
with pWS320; CmR,
ErmR; TEM-CagA
expression, ∆cagI
P12 TEM-CagA; ∆hopQ FSP21 P12[pWS486] transformed Schindele
with pFS10; CmR, (not published)
ErmR; TEM-CagA
expression, ∆hopQ
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2.2.2 Cultivation of bacteria
H. pylori were streaked from a glycerol stock on a serum plate and were cultivated under
microaerobic conditions at 37 ◦C and 5% O2, 10% CO2, 85% N2. After 48 h, bacteria were
passaged on a new serum plate every day. For experiments H. pylori were used after one
passage on a new serum plate. Serum plates consists of GC agar base (Oxoid) supple-
mented with 8% horse serum (PAA) and 1% vitamin mix. The vitamin mix consists of
100 g/L α-D-glucose, 10 g/L L-glutamine, 26 g/L L-cysteine, 1.1 g/L L-cystine, 0.15 g/L
L-arginine, 0.1 g/L cocarboxylase, 20 mg/L iron(III)nitrate, 3 mg/L thiamine, 13 mg/L
p-aminobenzoic acid, 0.25 g/L nicotinamide adenine dinucleotide, 10 mg/L vitamin B12,
1 g/L adenine, 30 mg/L guanine and 0.5 g/L uracil.
For experiments, bacteria were taken off a serum plate with a sterile cotton swab and
resuspended in PBS with 10% FCS. Then the optical density of the bacteria suspension
was determined with a spectrophotometer (DR 2000, Hach). For H. pylori, the optical
density was measured at a wave length of 550nm. At this wavelength, an optical density
of 0.1 correlates to approximately 2.5 x 10 7 CFU/mL.
2.2.3 Cryoconservation of bacteria
Bacteria from serum plates were resuspended in 70% Brucella Broth (BB) (Becton Dick-
inson) supplemented with 10% FCS (heat inactivated 20 min at 56 ◦C) and 20% glycerol
in cryogenic tubes (Nalgene, Thermo Fisher Scientific) and were stored at −80 ◦C.
2.3 In vitro infection
For an in vitro infection the optical density of the bacteria was measured with a spec-
trophotometer (see section 2.2.2) and the number of cells was determined (see section
2.1.6). Then, the bacteria were incubated with cells in PBS supplemented with 10% FCS
(heat inactivated 20 min at 56 ◦C) at a defined multiplicity of infection (MOI) at 37 ◦C
and 5% CO2.
2.3.1 Survival assay
Survival of phagocytosed bacteria was studied according to Odenbreit et al. [152]. Briefly,
2 x 10 5 cells were infected with an MOI of 25 for 0.5, 1 or 1.5 h with H. pylori P12, a
H. pylori P12 ∆hopQ, a H. pylori P12 ∆cagA, a H. pylori P12 ∆vacA or a H. pylori P12
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∆cagA∆vacA mutant. Afterwards adherent extracellular bacteria were killed by 1 h incu-
bation with 100 µg ml −1 gentamicin. After one hour cells were washed with PBS and the
cell membrane was permeabilized using PBS with 0.1% saponin. Then the supernatant
was plated on serum plates and after three days of incubation, the number of CFUs was
determined.
2.4 Biochemical methods
2.4.1 Bacterial and cellular lysates
For generation of bacterial and cellular lysates a defined number of bacteria or cells was
harvested by centrifugation. For chemokine measurements the supernatant was saved and
stored until further use, otherwise it was discarded. The pellet was resuspended in 2 x
SDS loading buffer and PBS* (Tab. 2.7). After an incubation at 95 ◦C for 10 min the
samples were stored at −20 ◦C until further analysis.
Tab. 2.7: Solutions for lysates
solution components
PBS* PBS
+ 1 mM phenylmethylsulfonyl fluoride
+ 1 mM sodium vanadate
+ 1 µM leupeptin
+ 1 µM pepstatin
2 x SDS-PAGE sample buffer 100 mM Tris-HCl pH 6.8
+ 4% (w/v) SDS
+ 20% (v/v) glycerol
+ 10% (v/v) β-mercaptoethanol
+ 0.2% (w/v) bromphenol blue
2.4.2 Sodium dodecyl sulfate polyacrylamide gel electrophoresis
Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) is a common
technique for separation of proteins. The proteins can then be immobilized and detected
in an immunoblot with specific antibodies. For separation of proteins, a resolving and a
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stacking gel were prepared. The components sufficient for one gel are listed in Tab. 2.8.
Tab. 2.8: SDS gel mixture
substance resolving gel (8%) stacking gel
ddH2O 2.3 ml 0.68 ml
acrylamide (Rotiphorese R© Gel 30 (37.5:1)) 1.3 ml 0.17 ml
1.5 M Tris/HCl, pH 8.8 1.3 ml
1.0 M Tris/HCl, pH 6.8 0.13 ml
10% SDS 0.05 ml 0.01 ml
ammonium persulfate 0.05 ml 0.01 ml
trichloroethanol 0.05 ml 0.01 ml
tetramethylethylenediamine 0.003 ml 0.001 ml
The resolving gel mixture was filled in the mini gel polymerization cassette between two
glas plates. After polymerization the stacking gel was loaded on top and a comb was
inserted for formation of slots. The samples were loaded in the polymerized SDS gel.
Page RulerTM Prestained Protein Ladder, 10 to 180 kDa (Fermentas) was used for a
marker. Electrophoresis was performed in SDS-PAGE running buffer with a voltage of
130 V in the mini-PROTEAN 3 Cell chamber gel electrophoresis system of BioRad. After
electrophoresis, protein bands of the SDS-PAGE were visualized using trichloroethanol
in the SDS gel on the ChemiDoc MP device from BioRad. Pictures were taken with the
Image Lab software.
2.4.3 Immunoblot
An Immunoblot, also known as Western blot, is an antibody based technique for detection
of proteins, which are separated by SDS-PAGE and immobilized on a membrane.
Blotting
After separation of proteins by SDS-PAGE, the proteins were transferred on a polyvinyli-
dene fluoride (PVDF) membrane using a semi dry blotting system (all buffers are listed
in Tab. 2.9).
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Tab. 2.9: Blotting buffer
solution anode I anode II cathode
Tris HCl 300 mM 25 mM 25 mM
pH 10.4 pH 10.4 pH 9.6
6-amino caproic acid - - 40 mM
methanol 10 % 10 % 10 %
For blotting thick Whatman papers saturated in anode I buffer followed by thin Whatman
papers soaked in anode II buffer were placed in a blotting chamber. The SDS gel were
put on a PDVF membrane activated in methanol (Sigma) and placed on the Whatman
papers. On top Whatman papers saturated in cathode buffer were stacked. Then a cur-
rent of 1.25mA/cm 2 for 70 min was applied to transfer the proteins from the gel to the
membrane. Afterwards the membrane was dried to fix proteins.
Detection of immobilized proteins
Next, the dried membrane was activated with methanol. Then, the membrane was blocked
with TBS-Tween buffer (TBS-T) supplemented with 3% BSA (see Tab. 2.10) for at least
1 h at RT. Primary antibody was added and incubated over night at 4 ◦C or for at least 3
h at RT. After washing four times with TBS-T the blot was incubated with the secondary
antibody for 45 min at RT, followed by washing four times. For the development of blots
incubated with a horseradish peroxidase (POX) coupled secondary antibody, Immobilon
Chemiluminescent HRP Substrate (Millipore) was used. The chemiluminescence reaction
was detected on an X-ray film (Fuji Medical X-Ray Films Super RX, Fujifilm). The de-
velopment solution of alkaline phosphatase (AP) blots is shown in Tab. 2.10. The blots
were incubated in the AP detection solution until the bands were visible. For detection of
another protein on the same membrane after chemiluminescence development the mem-
brane was incubated for 1 h using stripping solution (see Tab. 2.10).
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Tab. 2.10: Solutions for immunoblots
solution components
10x TBS 1.5 M NaCl
+ 200 mM Tris/HCl, pH 7.5
TBS-Tween buffer(TBST) 100 mL 10x TBS
+ 0.75 mL Tween 20
filled up to 1 L dH2O
AP development solution 100 mM Tris/HCl, pH 9.6
+ 7 mM MgCl2
+ 50 mg/L 5-Bromo-4-chloro-3-indolyl-
phosphate (BCIP)
+ 0.1 g/L Nitro blue tetrazolium (NBT)
stripping solution 25 mM glycine
+ 1% SDS
pH 2 with HCl
2.4.4 CagA phosphorylation
To test CagA phosphorylation, cells were infected with H. pylori for 3 h with a MOI 60.
The pellet was resuspended in PBS* (Tab. 2.7) and an immunoblot was performed as
described in 2.4.2-3. First, phosphorylated proteins were detected using the α-P-Tyr an-
tibody PY99 and then CagA was detected with the α-CagA antibody 299 (Tab. 2.11-12).
2.4.5 Antibodies - Immunoblots
All antibodies used for immunoblots in this work are listed in Tab. 2.11 and 2.12.
Tab. 2.11: Primary antibodies - immunoblots
antibody description finale concentration company/
reference
AK299 α-cagA 1:10000 W. Fischer
(EPIYA peptide)
PY99 monoclonal α-P-Tyr 1:5000 Santa Cruz
antibody (murine) Biotechnologies
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Tab. 2.12: Secondary antibodies - immunoblots
antibody description finale concentration company
reference
α-mouse POX POX coupled polyclonal 1:10000 Sigma
α-mouse IgG (goat)
ProteinA-AP AP coupled to proteinA 1:5000 Sigma
2.4.6 In vitro phosphorylation
An in vitro phosphorylation assay was performed to study whether kinases within the
cells are active and are able to phosphorylate CagA. Therefore 6 x 10 6 cells were cen-
trifuged and resuspended in NP40 cell lysis buffer (Tab. 2.13). 45 µl cells lysates, 45 µl
H. pylori and 11 µl phosphorylation buffer (Tab. 2.13) were incubated at 30 ◦C for 10
min. Afterwards 28 µl 5 x SDS sample buffer were added. After an incubation at 95 ◦C
for 10 min, the samples were analyzed in an immunoblot as described in section 2.4.2-3.
Tab. 2.13: Solutions for the in vitro phosphorylation
solution components
NP40 cell lysis buffer 20 mM Tris/HCl pH 7.5
+ 150 mM NaCl
+ 1% noident-P40
+ 1 mM EDTA
+ 1 mM PMSF
+ 1 mM sodium vanadate
+ 1 µM leupeptin
+ 1 µM pepstatin
phosphorylation buffer 250 mM Tris/HCl pH 7.2
+ 312.5 mM MgCl2x 4xH2O
+ 1 mM sodium vanadate
+ 400 µM ATP
36
2. MATERIAL AND METHODS
2.4.7 Src homology protein tyrosine phosphatase-1 inhibition
Protein phosphatases dephosphorylate proteins and regulate thereby signaling within the
cells. Src homology (SH2) protein tyrosine phosphatase-1 (SHP-1) down regulates signals
in hematopoietic cells [53]. According to Pathak et al., 99% of SHP-1 activity can be
inhibited by 5 min incubation of the cells with 10 µg/ml sodium stibogluconate (Cayman
chemicals) [153]. Additionally, the SHP-1 activity was inhibited according to Cho et al.
by incubating the cells with 100 µM hydrogen peroxide for 30 min at 37 ◦C [154].
2.5 Flow cytometry
Flow cytometry is a technique to detect the size, the granularity and the fluorescence of
single cells. The cells are separated by high pressure in the flow cytometer, all passing a
forward scatter, detecting their size, a sideward scatter, detecting their granularity and a
laser light exciting fluorophores in the cells or bacteria producing fluorescence emission.
2.5.1 Antibodies - flow cytometry
Tab. 2.14 lists all antibodies used for flow cytometry in this work.
Tab. 2.14: Antibodies - flow cytometry
(APC = allophycocyanin, FITC = fluoresceinisothiocyanat, PE = phycoerythrin)
antibody clon company
FITC anti mouse/human CD11b M1/70 Biolegend
PE anti mouse CD11c HL3 BD Bio Science
α-human CD66abce-APC TET2 Miltenybiotec
α-human CEACAM1 4/3/17 Aldevron
α-human CEACAM3 col1 Aldevron
α-human CEACAM6 9A6 Aldevron
APC rat anti mouse Ly6G 1A8 Biolegend
PE Cy5 anti mouse F4/80 Bm8 e Bio Science
Rat IgG2a κ isotype control APC eBR2a Biolegend
Rat IgG2a κ isotype control FITC BD Bio Science
Rat IgG2a κ isotype control PE eBR2a e Bio Science
Rat IgG2a κ isotype control PE Cy5 eBR2a e Bio Science
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2.5.2 Cell characterization
Neutrophils, MΦ and DCs were characterized by flow cytometry analysis. After blocking
of FC receptors using goat serum, 2 x 10 5 cells were stained with antibodies (see Tab 2.14)
according to the guidelines of the manufacturer. The primary or conjugated antibodies
were incubated for 1 h at 4 ◦C and the secondary antibodies for 45 min at 4 ◦C. In between
and afterwards the cells were washed three times with flow cytometry buffer consisting
of PBS + 2 mM EDTA + 0.1% BSA and 0.5% FCS. Finally, the sample analysis was
performed at the BD CantoII flow cytometer and the data were studied using FlowJo
software (Tree Star).
2.5.3 CEACAM expression
The CEACAM expression was measured via flow cytometry analysis, too. Therefore the
assays were performed as described in section 2.5.2. The antibodies used are listed in Tab
2.14. They were used according to the instruction of the manufacturer with 1.2 µg/10 6
cells. Goat α-mouse Alexa488 was used as secondary antibody.
2.5.4 Interaction experiment
For analysis of the interaction of H. pylori and immune cells in general, 2 x 10 5 cells were
infected with an MOI of 10 for 1 h with H. pylori P12 wt GFP and H. pylori P12 ∆hopQ
GFP. Strains, which do not express GFP, were stained with 5 mg/ml 4, 6-Diamidin-2-
phenylindol (DAPI) for 10 min and afterwards washed with PBS to be used for infection.
After 1 h of infection cells were washed with flow cytometry buffer. Finally, the GFP or
DAPI signal was detected by flow cytometry. Fluorescence intensities were normalized to
uninfected cells. In addition, the GFP or DAPI intensities were normalized to the P12
wt strain.
2.5.5 Binding assay
Binding of H. pylori to cells was analyzed using flow cytometry. For this phagocytosis was
inhibited by adding 10 µg/ml cytochalasin D. In detail, neutrophils were infected with an
MOI of 25 for 1 h with H. pylori P12 wt GFP and H. pylori P12 ∆hopQ GFP. Afterwards
cells were washed with flow cytometry buffer and binding was measured by flow cytometry.
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2.5.6 Phagocytosis assay
Phagocytosed bacteria were detected by flow cytometry using trypan blue according to
the protocol of Pils et al. [155]. For this PMNs were infected with an MOI of 25 for 1 h
with H. pylori P12 wt GFP and H. pylori P12 ∆hopQ GFP. Then the cells were washed
and the permeable substrate trypan blue was added to quench the green fluorescent signal
of adherent bacteria. Finally, the green fluorescence signal of intracellular, phagocytosed
bacteria was analyzed by flow cytometry.
2.5.7 Detection of ROS
ROS were detected according to the method of Chen et al. by flow cytometry. In de-
tail, neutrophils infected with H. pylori with an MOI of 60 were incubated for 20 min
at 37 ◦C with dihydrorhodamine123. Meanwhile by production of ROS, the non fluo-
rescent dihydrorhodamine is oxidized to green fluorescent rhodamine. Afterwards, the
cells were centrifuged and fixed with 4% paraformaldehyd in flow cytometry buffer (see
section 2.5.2) on ice. Finally, the green fluorescence was analyzed by flow cytometry [156].
2.5.8 Quantification of CagA translocation
For quantification of CagA translocation the method of Schindele et al. was used [151].
H. pylori P12 [TEM-CagA] strains were incubated for 1.5 h in PBS with 10% FCS at
37 ◦C. Afterwards cells were infected for 2.5 h with the preincubated H. pylori strains.
After centrifugation the supernatant was discarded and a CCF4-AM loading solution
(Live-BLAzer-FRET B/G loading kit, Invitrogen) supplemented with 1 mM probenecid
(Sigma) was added (Tab. 2.15). The samples were incubated for 1.5 h at RT in the dark
on a shaker. Then, the samples were washed three times with flow cytometry buffer and
analyzed by flow cytometry.
The CCF4-AM is colorless outside of the cell. Within the cell CCF4-AM is activated by
cellular esterases and shows a green fluorescence. If TEM-CagA is translocated into the
cell, CCF4-AM is cleaved and shows a blue fluorescence. Cells containing TEM-CagA
show in addition a blue fluorescence. Whereas cells without CagA are not fluorescent in
blue.
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Tab. 2.15: Components of the CCF4-AM loading solution
solution components
CCF4-AM loading solution [1ml] 828 µl DPBS
+ 1 µl 1 mM CCF4-AM
+ 10 µl solution B
+ 156 µl solution C
+ 5 µl 200 mM probenecid
2.5.9 Chemokine measurement
For analysis of chemokine production, the supernatant of infected neutrophils, MΦ and
DCs was collected. Chemokine measurements were performed with the LEGENDplex
kit (BioLegend) according to the manufacturers instructions. The principle of the LEG-
ENDplex kit is a bead-based sandwich immunoassay. The chemokines bind to a specific
antibody conjugated to beads, which were detected by biotinylated antibodies (Strep-
tavidin, R-Phycoerythrin Conjugate (SAPE)). The samples were measured using flow
cytometry and the data were analyzed with the LEGENDplex software.
2.6 Microscopy
2.6.1 Confocal microscopy of H. pylori - neutrophil interaction
Besides flow cytometry, the interaction of H. pylori with neutrophils was studied by con-
focal microscopy. Therefor neutrophils were infected for 1 h with an MOI of 10 with a H.
pylori wt strain. Afterwards 2 x 10 5 neutrophils were transferred to a microscopy slide by
using a cytospin3 (Shandon) and were fixed with 4% formaldehyde (PFA) solution. For
immunostaining non-specific binding sites of the cells were blocked with 5% goat serum
over night. CEACAMs were stained in red with the pan CEACAM antibody (D14HD11,
Genovac, 1:200) and a goat anti mouse Alexa555 secondary antibody (Invitrogen). H. py-
lori was stained in green with a rabbit anti-H. pylori (AK175, 1:400) and a goat α rabbit
Alexa488 secondary antibody (Invitrogen). Moreover, the nuclei were stained with DAPI
(5 µg/ml) and the cell shape with wheat germ agglutinate (WGA)-Alexa647 (5 µg/ml)
for 10 min. Then cells were mounted with mounting medium (Dako) and were analyzed
using a 63x oil immersion objective of the confocal Laser Scanning Microscope (LSM880,
Zeiss) with Airyscan Module. Micrographs were analyzed with ImageJ/Fiji.
In addition, to distinguish between extra- and intracellular bacteria immune stainings
40
2. MATERIAL AND METHODS
were performed with extracellular bacteria stained with rabbit anti-H. pylori (AK175,
1:400) and a goat α rabbit Alexa555 secondary antibody in red. Afterwards the cell
shape of the nuclei were stained with WGA-Alexa647. Extra- and intracellular bacteria
were stained after cell permeabilization with Triton X-100 using the same primary anti-
body and a goat α rabbit Alexa488 secondary antibody in green. Furthermore, cell nuclei
were stained with DAPI. Micrographs were taken with the 63x oil immersion objective
of the confocal Laser Scanning Microscope (LSM880, Zeiss) with Airyscan Module. In
addition to ImagJ/Fiji, the Imaris software (Bitplane AG) was used to analyze the mi-
crographs.
2.6.2 Giemsa staining
The differentiated MPRO neutrophil cell lines (Tab. 2.3) and bone marrow derived neu-
trophils were stained with Giemsa solution to check for differentiation of the cells. For
this 2 x 10 5 cells were centrifuged, the supernatant was discarded and the cell pellet was
resuspended in 100 µl PBS supplemented with 0.5% BSA. Then, the cells were centrifuged
in a cytospin3 at 1500 rpm for 5 min. The sample was incubated for 5 min in methanol,
followed by an incubation for 30 min in Giemsa solution. Afterwards, the sample was
washed in ddH2O.
2.7 CRISPR/Cas9
The specific genome editing technique CRISPR/Cas9 was used in this work to delete SHP-
1 and/or murine CEACAM 1 in MPRO and MPRO CEACAM cells. CRISPR stands for
Clustered Regularly Interspaced Short Palindromic Repeats. These are gene sequences in
bacteria that are able to destroy phage DNA. For the knockout the CRISPR guide RNAs
were designed to lead the Cas9 nickase to the target sequence of exon 2 of SHP-1 (see Fig.
2.1 A) or exon 1 of murine CEACAM1 (see Fig. 2.1 B), where a double strand break is
induced. This break gets repaired by non-homologous end-joning repair, which results in
mutations in the gene of interest.
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A 
Murine SHP-1 locus 
Guide B 
IKB11: 5´  CACCGTCGGCCCAGCCGCAAGAACC 3´ 
IKB12: 3´            CAGCCGGGTCGGCGTTCTTGGCAAA 5´ 
Guide A 
IKB9: 5´ CACCGGGACTCCCCGGCCCTTCAGC 3´ 
IKB10: 3´         CCCTGAGGGGCCGGGAAGTCGCAAA  5´ 
exon 2 
exon 2 
5´… ACCCTGCTGAAGGGCCGGGGAGTCCCTGGGAGCTTCCTGGCTCGGCCCAGCCGCAAGAACCAGGGT …  3´ 
3´… TGGGACGACTTCCCGGCCCCTCAGGGACCCTCGAAGGACCGAGCCGGGTCGGCGTTCTTGGTCCCA …  5´ 
 
Guide B 
Guide A 
exon 1 
Murine CEACAM1 locus 
Guide A 
IKB1: 5´ CACCGTCCAACACTACTGCTAAGCC 3´ 
IKB2: 3´           CAGGTTGTGATGACGATTCGGCAAA  5´ 
B 
Guide B 
IKB3: 5´ CACCGCCTCAGCACATCTCCACAAA 3´ 
IKB4: 3´           CGGAGTCGTGTAGAGGTGTTTCAAA  5´ 
exon 1 
Guide B 
Guide A 
5´… AGCCTGGCTTAGCAGTAGTGTTGGAGAAGAAGCTAGCAGGCAGGCAGCAGAGACATGGAGCTGGCCTCAGCACATCTCCACAAAGGGCA … 3´ 
3´… TCGGACCGAATCGTCATCACAACCTCTTCTTCGATCGTCCGTCCGTCGTCTCTGTACCTCGACCGGAGTCGTGTAGAGGTGTTTCCCGT … 5´ 
PAM 
PAM 
PAM 
PAM 
PX461-910 
BbsI BbsI 
Cas9n GFP U6 
pSpCas9n(BB)-2A-GFP (PX461) 
BGH polyA NLS NLS CBh 
PX461-12 
BbsI BbsI 
Cas9n GFP U6 
pSpCas9n(BB)-2A-GFP (PX461) 
BGH polyA NLS NLS CBh 
PX461-1112 
BbsI BbsI 
Cas9n GFP U6 
pSpCas9n(BB)-2A-GFP (PX461) 
BGH polyA NLS NLS CBh 
PX461-34 
BbsI BbsI 
Cas9n GFP U6 
pSpCas9n(BB)-2A-GFP (PX461) 
BGH polyA NLS NLS CBh 
Fig. 2.1: CRISPR/Cas9 deletion strategy for SHP-1 and murine CEACAM1
CRISPR/Cas9 deletion strategy: For murine SHP-1 (A) guide RNA, located in exon 2 and for murine
CEACAM1 (B), guide RNAs in exon 1, followed by the 5‘NGG PAM (protospacer adjacent motif) (blue).
All this was cloned in the vector pSpCas9n(BB)-2A-GFP (PX461).
For this study the CRISPR guide RNAs were designed using the online tool http://tools.
genome-engineering.org/ (see Tab. 2.16).
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Tab. 2.16: CRISPR/Cas9 primer list
primer sequence target/reference
IKB9 CACCGGGACTCCCCGGCCCTTCAGC SHP-1
IKB10 AAACGCTGAAGGGCCGGGGAGTCCC SHP-1
IKB11 CACCGTCGGCCCAGCCGCAAGAACC SHP-1
IKB12 AAACGGTTCTTGCGGCTGGGCCGAC SHP-1
IKB1 CACCGTCCAACACTACTGCTAAGCC murine CEACAM1
IKB2 AAACGGCTTAGCAGTAGTGTTGGAC murine CEACAM1
IKB3 CACCGCCTCAGCACATCTCCACAAA murine CEACAM1
IKB4 AAACTTTGTGGAGATGTGCTGAGGC murine CEACAM1
ZQ66 GAGGGCCTATTTCCCATGATTCC [128]
The two oligos were annealed using 1 µl of each oligo, 2 µl T4 ligase buffer (NEB), 1 µl
T4 ligase and 16 µl ddH2O for 5 min at 95
◦C and stored at 4 ◦C. The Cas9 nikase-GFP
vector Px461 (Cas9n-GFP) (pSpCas9n(BB)-2A-GFP (PX461)) [157] was digested with
BbsI for 3 h at 37 ◦C (see Tab. 2.17). Then the ligation components were added to the
digestion.
Tab. 2.17: Components of the Cas9n-GFP vector digestion
components
digestion of the vector 2 µl 10x cut smart buffer (Biolabs)
+ 4.22 µl vector Px461 (Cas9n-GFP) (1 µg/µl)
+ 13.78 µl ddH2O
+ 0.3 µl BbsI (NEB)
Next 1 µl annealed oligos were incubated with 2.5 µl 10x ligase buffer and 1.2 µl T4 DNA
ligase (NEB) for 1 h at RT. For transformation 2 µl were added to 10 µl stbl3 chemical
competent E. coli cells. After a heatshock at 42 ◦C for 30 s they were incubated for 2
min on ice. 500 µl SOCS medium was added and 100 µl of the sample was plated on a
LB Ampicillin (100 mg/L) plate. After one day clones were picked and the plasmids were
extracted using the Qia prep Spin Mini prep Kit 250 following the instructors manual.
The extracted plasmids were sequenced using ZQ66 (see Tab. 2.16, primer list) to check
the right insertions of the oligos.
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Then 1 µg (or 0.5 µg by double deletions) of the sgRNAs and 0.5 µg of the plasmid contain-
ing the Cas9 nikase-GFP vector Px461 (Cas9n-GFP) (pSpCas9n(BB)-2A-GFP (PX461))
construct were transfected in MPRO, MPRO CEACAM 1 and MPRO CEACAM 3 cells
by electroporation using program T-20 according to Cullere et al. [158].
Afterwards the cells were sorted by GFP signals using fluorescence activated cell sorting
at the flow cytometry unit of the TU Munich. Finally, the sorted cells were cultured and
cells were cryconserved (see section 2.1.7).
2.8 2D migration
The under agarose migration assay is a method to study the 2D migration of cells. It was
performed according to the protocol of Heit and Kubes An 8 well chamber slide (ibidi)
was coated for 30 min at 37 ◦C with 0.1% BSA in HBSS, pH 7.2 (Sigma). 400 µl agarose
solution consisting of 2 x HBSS, RPMI 1640 + 20% FCS in a 1:1 mixture and 1.6% ultra
pure agarose (Invitrogen) were filled in the 8 wells chamber slide (ibidi), which were then
incubated for 1 h at 37 ◦C under wet conditions. Then, two slots with a diameter of 3.5
mm were punched in the agarose of one well of the 8 Well chamber slide and the slide were
incubated again for 1 h. Afterwards a chemoattractant were filled in one slot. After 1 h
the chemoattractant gradient was formed and 1 x 10 6 cells were filled in the other slot.
The migration of the cells under the agarose gel was studied by time-lapse microscopy us-
ing a 10x objective of the SP5 confocal microscope (Leica). The analysis was performed
with the Manual Tracking Plugin for ImageJ and the Chemotaxis and Migration Tool
(ibidi).
2.9 Statistics
All experiments were performed independent at least three times. Data sets show average
values with the standard error of mean. For data analysis GraphPadPrism 5 software
(GraphPad) was used. Other analysis programs are mentioned in the different sections.
Statistical analysis of independent groups was performed using Two way ANOVA, with
a Bonferroni post hoc test.
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3. Results
3.1 The role of human CEACAMs for the interaction
of H. pylori with neutrophils
3.1.1 CEACAM expression in neutrophils
For analysis of the role of human CEACAMs for the interaction of H. pylori with PMNs,
bone-marrow derived neutrophils were isolated from murine wt and different humanized-
CEACAM mice expressing: hCEACAM1, hCEACAM3, 6 and hCEACAM1, 3, 6 (see
section 2.1.2, Tab. 2.1). In addition, neutrophils, isolated from human blood of healthy
adult volunteers were used as controls. The isolated neutrophils were characterized and
their expression of human CEACAMs was studied by flow cytometry (Fig. 3.1 and 3.2).
murine PMNs
Ly6G high
murine PMNs
Giemsa staining
human PMNs
CD66abce high
murine PMNs
CD11b high
isotype control
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t
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A B C D
APC-A FITC-A
10 µm
Fig. 3.1: Characterization of isolated neutrophils
A-C) Isolated human (A) and murine (B and C) neutrophils were characterized by flow cytometry using
the following antibodies: CD66abce-APC (TET2) (Miltenybiotec) (red), Ly6G-APC (1A8) (Biole-
gend) (blue), CD11b-FITC (M1/70) (Biolegend) (black) and the isotype controls rat IgG2a κ FITC
(BD BioScience) as well as rat IgG2a κ APC (Biolegend) (shaded histograms). The graphs in A-C
show a representative experiment of at least three.
D) The typical donut shaped nuclei of neutrophils were observed using Giemsa staining.
The isolated human neutrophils expressed the characteristic surface marker CD66abce
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(see Fig. 3.1 A, red), while the murine neutrophils were identified by the typically murine
neutrophil markers Ly6G (Fig. 3.1 B, blue) in combination with CD11b (black). More-
over, the hallmark of differentiated neutrophils, the donut shaped nuclei, was shown by a
staining with Giemsa (Fig. 3.1 D).
Next, Fig. 3.2 illustrates the result of the CEACAM expression analysis.
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Fig. 3.2: CEACAM expression of human, murine and humanized neutrophils
CEACAM expression was studied by flow cytometry using the following antibodies: CEACAM1 (3/4/17,
Genovac) (red), CEACAM3 (col-1, Thermo Fisher) (green), CEACAM6 (9A6, Genovac) (blue) and a
Alexa488 conjugated secondary antibody (isotype control) (shaded histogram).
A-E) The graphs show a representative experiment of at least three independent experiments.
F, G) Quantification of CEACAM expression. All bars over the dashed blue line show CEACAM expres-
sion. Statistics was performed using Two way ANOVA, with a Bonferroni post hoc test. The error
bars show the standard error of mean (SEM), * < 0.05, ** < 0.01, *** < 0.001.
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Human CEACAM1 (see Fig. 3.2 F) was detected in low levels in human (black), hCEA-
CAM1 (red) and hCEACAM1, 3, 6 neutrophils (purple). High expression levels were mea-
sured for human CEACAM6 (Fig. 3.2 G) in human (black), hCEACAM3, 6 (turquoise)
and hCEACAM1, 3, 6 neutrophils (purple). Here, the CEACAM6 expression of hCEA-
CAM3, 6 PMNs (Fig. 3.2 G, turquoise bar) shows a significant higher level in comparison
to human PMNs (black bar) and hCEACAM1, 3 and 6 PMNs (purple bar).
All in all, flow cytometry analysis revealed that human and humanized neutrophils ex-
pressed human CEACAM1 and 6 (Fig. 3.2), whereas murine wt PMNs (gray bar) do not
express human CEACAMs. The expression of human CEACAM3 (Fig. 3.2 F) was weak.
Chan et al. already reported about difficulties in the detection of human CEACAM3 [138].
3.1.2 Interaction of H. pylori with neutrophils
Binding of pathogens to host cells is an initial step in an infection process. Thus, human,
murine and the different humanized CEACAM neutrophils were infected with H. pylori wt
GFP or ∆hopQ GFP mutant strains for 1 h with an MOI of 10 to analyze their interaction
by flow cytometry and confocal microscopy (see Fig. 3.3-4).
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Fig. 3.3: Analysis of the interaction of H. pylori with PMNs by flow cytometry
Flow cytometry analysis of different PMNs infected with P12 wt GFP (black) or a P12 ∆hopQ GFP
mutant strain (gray) or left uninfected (white) by flow cytometry. Statistics was performed using Two
way ANOVA, with a Bonferroni post hoc test. The error bars show the SEM of at least three independent
experiments, * < 0.05, ** < 0.01, *** < 0.001.
High fluorescence intensities were seen in human and humanized neutrophils infected with
H. pylori P12 wt GFP (see Fig.3.3 A, black). Murine PMNs without human CEACAMs
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showed three to four times lower fluorescence intensities than human or humanized PMNs.
These data indicated a CEACAM dependent increase of the interaction of H. pylori with
neutrophils expressing human CEACAMs. This result was supported by the significantly
reduced fluorescence signal in an infection with the P12 ∆hopQ GFP mutant strain (gray),
lacking the adhesin to interact with CEACAMs. Consistent with these results, in murine
wt PMNs no difference was revealed between the P12 wt GFP (black) and the P12 ∆hopQ
GFP mutant strain (gray). When comparing several groups of humanized CEACAM
PMNs, it can be seen that they do not differ in their interaction with the bacterium.
Next, Fig. 3.4 shows micrographs of infected humanized-CEACAM and murine PMNs.
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Fig. 3.4: Confocal microscopy of CEACAM expression and binding of H. pylori to PMNs
HCEACAM1, 3, 6 (A) and murine PMNs (B) were infected with H. pylori, fixed on microscopy slides and
stained with antibodies. Merged (1), α-CEACAM and Alexa555 (2), H. pylori α-AK175 and Alexa488
(3), nuclei DAPI (4), cell shape WGA-Alexa647 (5). Shown are 3D image projections of z-stacks from
the confocal microscopy images.
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The confocal microscopy of infected hCEACAM1, 3, 6 PMNs (see Fig.3.4, A), expressing
all human CEACAMs on PMNs, and murine PMNs (B) stained with antibodies against
CEACAMs (red) and H. pylori (green) demonstrates differences in the interaction of H.
pylori with neutrophils. Many bacteria (green) interact with hCEACAM1, 3, 6 PMNs,
expressing a high amount of CEACAMs (red), while only a few bacteria interact with
murine PMNs. Thus, the flow cytometry analysis data were confirmed by confocal mi-
croscopy images of infected humanized-CEACAM and murine PMNs. Taken together,
human CEACAMs enhance the interaction of H. pylori P12 with PMNs.
Furthermore, it was studied whether other H. pylori strains show the same CEACAM
dependent effect in the interaction with the bacterium (see Fig. 3.5).
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Fig. 3.5: Study of the interaction of different H. pylori strains with PMNs
The interaction of several H. pylori wt or ∆hopQ mutant strains either expressing GFP or stained with
DAPI with the different neutrophil populations was analyzed after an infection for 1 h with an MOI of
10 by flow cytometry. Statistics was performed using Two way ANOVA, with a Bonferroni post hoc test.
The error bars show the SEM of at least three experiments, * < 0.05, ** < 0.01, *** < 0.001.
The analysis of the interaction of several H. pylori strains with PMNs showed high fluores-
cence intensities in infections with humanized neutrophils, demonstrated by a CEACAM
dependent increase of the interaction with PMNs, which is independent of the H. pylori
strain. These result were supported by lower fluorescence intensities in murine PMNs with-
out human CEACAMs. In addition, the different interaction experiments with murine wt
PMNs did not show a difference between an infection of the H. pylori wt or ∆hopQ mu-
tant strains. However, in an infection of humanized PMNs with the 26695 ∆hopQ mutant
strain the fluorescence intensity was reduced. These results support the CEACAM effect.
Only in infections of the G27 ∆hopQ mutant strains with hCEACAM1 and hCEACAM3,
6 PMNs the fluorescence intensity of the bacteria did not show a reduction. However,
further experiments are necessary to prove this finding. Interestingly, neutrophils infected
with the gerbil adapted B8 strain showed a high fluorescence intensity. Moreover, a low
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CEACAM effect was observed in the infection with the mouse adapted SS1 strain.
In conclusion, experiments with various independent H. pylori strains revealed that hu-
man CEACAMs increase the interaction of H. pylori with neutrophils. However, with this
approach it was not possible to distinguish between adhesion and phagocytosis. Thus,
other experiments were performed to study this aspect separately (see Fig. 3.6).
3.1.3 Binding versus phagocytosis of H. pylori
Besides binding of H. pylori to neutrophils, these cells are able to phagocytose the bac-
terium. Fig. 3.6 A demonstrates binding of H. pylori to neutrophils incubated with
cytochalasin D, a drug, which inhibits the process of phagocytosis. Fig. 3.6 B quantifies
phagocytosis of the bacteria by neutrophils using trypan blue to quench the signal of
external bacteria.
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Fig. 3.6: Analysis of binding versus phagocytosis of H. pylori
A) Binding was analyzed after an infection with a P12 GFP and ∆hopQ GFP mutant strain with an
MOI of 25 for 1 h using neutrophils incubated with cytochalasin D (Cyt. D) to inhibit phagocytosis
by flow cytometry. Statistics was performed using Two way ANOVA, with a Bonferroni post hoc
test. The error bars show SEM of at least three experiments, * < 0.05, ** < 0.01, *** < 0.001.
(B) Phagocytosis was studied under the same conditions without cytochalasin D addition. To quench
the signal of adherent bacteria trypan blue (TB) was added shortly before flow cytometry analysis.
Humanized neutrophils incubated with cytochalasin D showed a significant higher fluo-
rescence intensity compared to murine neutrophils (see Fig. 3.6 A). Moreover, the fluores-
cence intensity was reduced in an infection with the ∆hopQ mutant strain. This indicated
that H. pylori binds to neutrophils depending on CEACAMs. Humanized neutrophils,
which were not incubated with cytochalasin D, exhibit a higher fluorescence intensity
compared to humanized neutrophils with inhibited phagocytosis. Therefore, it could be
concluded that neutrophils phagocytose H. pylori. Notably, no difference was detected
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in the fluorescence intensity of PMNs treated with cytochalasin D compared to PMNs
without cytochalasin D infected with the ∆hopQ mutant strain.
In Fig. 3.6 B the signal of adherent bacteria was quenched by trypan blue. Here, the
humanized neutrophils showed a significantly higher fluorescence intensity, whereas the
fluorescence intensity in murine neutrophils and in an infection with the ∆hopQ mutant
strain was three times lower. Accordingly, phagocytosis of the bacteria is dependent on
CEACAMs. When comparing several groups of humanized CEACAM PMNs, it can be
seen that they do not differ in their binding and phagocytosis. All in all, consistent with
the results of the interaction experiments, binding and phagocytosis of H. pylori are en-
hanced in PMNs expressing human CEACAMs.
3.1.4 Survival of H. pylori after phagocytosis by PMNs
Allen et al. reported that H. pylori is able to evade killing by disrupting NADPH oxidase
[60]. Humanized neutrophils phagocytose H. pylori more efficiently compared to murine
neutrophils, as it was demonstrated in the previous section. Thus, a plating assay was
performed to quantify bacteria surviving the phagocytosis of murine versus the different
humanized CEACAM neutrophils. Therefore, PMNs were infected with H. pylori P12 and
∆hopQ mutant strain for 30 min, 1 h and 1.5 h with an MOI of 25. Then, after eliminating
extracellular bacteria with gentamicin and permeabilization of cells with saponin, samples
were plated on serum plates. After three days, the CFUs were counted (Fig. 3.7).
A B
1 hour
Fig. 3.7: Study of survival of H. pylori after phagocytosis by PMNs
Survival of phagocytosis were analyzed using the gentamicin killing assay. Statistics of at least three
independent experiments was performed using Two way ANOVA, with a Bonferroni post hoc test. The
error bars show the SEM, * < 0.05, ** < 0.01, *** < 0.001.
A) The bar chart shows the CFUs after 1 h of infection.
B) The dot plot shows the phagocytosis surviving bacteria after an infection of neutrophils for 0.5, 1 and
1.5 h with H. pylori.
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The survival assay indicates that H. pylori survives phagocytosis of neutrophils. Remark-
ably, in neutrophils of humanized CEACAM3, 6 mice (turquoise bar) ten times more H.
pylori (wt) survive phagocytosis compared to murine PMNs (gray), five times more bac-
teria survive compared to hCEACAM1 (red bar) and two times more H. pylori survive
compared to hCEACAM1, 3, 6 PMNs (Fig. 3.7 A, purple bar). Furthermore, survival
depends on CEACAMs as it was confirmed by the results of the infection using the ∆hopQ
mutant strain.
Notably, an infection with P12 wt of hCEACAM1 neutrophils (red) showed a five times
lower survival rate of H. pylori compared to hCEACAM3, 6 neutrophils (turquoise). More-
over, hCEACAM1 PMNs infected with the P12 ∆hopQ mutant strain did not show a
reduced survival and consequently no CEACAM effect. A hallmark of hCEACAM1 are
the two ITIM motifs (see section 1.4.2) leading to inhibitory signaling cascades. Thus,
hCEACAM1 seems to play an opposite role in surviving phagocytosis. Furthermore, even
hCEACAM1, 3, 6 neutrophils demonstrated a reduced survival rate compared to hCEA-
CAM3, 6 PMNs. But, comparing both humanized PMNs with lower surviving rates, the
survival in hCEACAM1, 3, 6 is two times higher compared to hCEACAM1 PMNs.
Next, the survival of H. pylori in PMNs was analyzed over a time period up to 1.5 h. The
survival rate of the bacterium in hCEACAM3, 6 PMNs strongly increased in the first hour
of infection (see Fig. 3.7 B). After 1 h the amount of surviving bacteria doubled compared
to 0.5 h, whereas after 1.5 h nearly the same amount of bacteria survives in hCEACAM3,
6 PMNs compared to the results after 1 h of infection. In murine and hCEACAM1 PMNs
only a few bacteria survive phagocytosis independent of the time period of infection, while
in hCEACAM1, 3, 6 PMNs the amount of surviving bacteria increase up to one hour and
reaches a plateau as well as hCEACAM3,6 PMNs. However, after 1.5 h of infection two
times more bacteria survive in hCEACAM3, 6 PMNs compared to hCEACAM1, 3, 6
PMNs. Taken together, these data suggest that CEACAM3 and/or 6 seem to support
survival of H. pylori in PMNs.
Allen et al. could demonstrate differences in phagocytosis by MΦ of strains, which do
not contain CagA and VacA [61]. Raising the question, whether CagA and VacA are also
involved in the survival of phagocytosis in neutrophils. However, Odenbreit et al. did not
detected differences in phagocytosis by MΦ of strains, which do not contain CagA and
VacA [152]. Thus, the gentamicin killing assay were performed with H. pylori ∆cagA and
∆vacA mutant strains (see Fig. 3.8).
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Fig. 3.8: Study of survival of H. pylori ∆cagA and ∆ vacA after phagocytosis by PMNs
Survival of phagocytosis of H. pylori ∆cagA and ∆vacA were analyzed using the gentamicin killing assay.
Statistics of at least three independent experiments was performed using Two way ANOVA, with a
Bonferroni post hoc test. The error bars show the SEM, * < 0.05, ** < 0.01, *** < 0.001. The dot plot
shows the phagocytosis surviving bacteria after an infection of PMNs for 1 h.
The survival assay showed that infections with a H. pylori ∆cagA and/or ∆vacA mutant
strain of murine and hCEACAM1 PMNs showed lower survival rates of the bacteria com-
pared to hCEACAM3, 6 PMNs. In an infection of hCEACAM3, 6 PMNs with a H. pylori
∆cagA mutant strain (dark gray) the survival probability is approximately 10% lower in
comparison to P12 wt bacteria (black). Furthermore, in an infection of PMNs with a H.
pylori ∆vacA mutant strain (light gray) the probability of survival of phagocytosis drops
about 25% in comparison to P12 wt bacteria. Notably, in an infection of hCEACAM3,
6 PMNs with a ∆cagA∆vacA mutant strain (white) only half of the amount of bacteria
survive phagocytosis in comparison to P12 wt bacteria. Thus, CagA and VacA seems to
have an influence on survival of phagocytosis in hCEACAM3, 6 PMNs. In hCEACAM1,
3, 6 PMNs a deletion of CagA did not influence survival of phagocytosis, while a deletion
of VacA leads to a small reduction of survival of phagocytosis in comparison to P12 wt
bacteria. Surprisingly, even more H. pylori with a deletion of CagA survive phagocytosis
in hCEACAM1, 3, 6 PMNs. In murine and hCEACAM1 neutrophils no difference can
be seen between H. pylori wt and ∆cagA or ∆vacA mutant strains. All in all, the data
suggest that especially VacA is involved in survival of phagocytosis by humanized PMNs.
3.1.5 Production of reactive oxygen species
As mentioned in section 3.1.4, H. pylori is able to disrupt NADPH oxidase resulting in a
strong extracellular release of ROS. Thus, ROS production was analyzed in murine and
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humanized neutrophils measuring NADPH oxidase activity using dihydrorhodamine (see
Fig. 3.9).
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Fig. 3.9: Analysis of ROS production by PMNs
ROS production was studied using dihydrorhodamine, which reacts in the presence of ROS to green
fluorescent rhodamine. Statistics was performed using Two way ANOVA, with a Bonferroni post hoc
test. The error bars show the SEM of at least three experiments, * < 0.05, ** < 0.01, *** < 0.001.
The ROS analysis showed that hCEACAM3, 6 (see Fig. 3.9, turquoise bar) as well as
hCEACAM1, 3, 6 PMNs (purple bar) showed two to three times higher fluorescence in-
tensity compared to hCEACAM1 neutrophils (red bar) and murine PMNs (gray bar).
Thus, hCEACAM3, 6 and hCEACAM1, 3, 6 PMNs produced significantly more ROS
(2-3 times) compared to hCEACAM1 neutrophils and murine PMNs. Incubation of H.
pylori ∆hopQ with neutrophils led to a reduced fluorescence intensity and consequently a
lower ROS release. This indicated that, consistent with the survival of phagocytosis, ROS
production is CEACAM3 and 6 dependent. However, the interaction of H. pylori with
human CEACAM1, consisting of two ITIM motifs, resulted in a lower ROS production,
eventually due to the general inhibitory function of human CEACAM1.
3.1.6 Confocal microscopy studies of the interaction of H. pylori
and PMNs
Besides flow cytometry and the survival assay the interaction of H. pylori and neutrophils
was studied using confocal microscopy (see Fig. 3.9). In addition, it was differentiated
between extracellular H. pylori stained in green with red dots by a double staining with
an anti-H. pylori antibody and a secondary Alexa555 as well as an anti-H. pylori antibody
and a secondary Alexa488 antibody, while intracellular H. pylori were stained after per-
meabilization in green by an anti-H. pylori antibody and a secondary Alexa488 antibody.
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Fig. 3.10: Interaction of H. pylori and PMNs studied by confocal microscopy
Murine (A) and hCEACAM1, 3, 6 (B, C) PMNs were infected with H. pylori, fixed on microscopy slides
and stained with antibodies. Merged with zoom in (1), H. pylori extern α-AK175 and Alexa555, (2) after
permeabilization H. pylori extern and intern α-AK175 and Alexa488 , (3) nuclei DAPI, (4) cell shape
WGA-Alexa647. Shown are 3 D image projections of z-stacks from the confocal microscopy images.
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Confocal microscopy of infected murine wt PMNs (see Fig. 3.10, A) showed binding of a
few H. pylori (green with orange dots) to murine wt neutrophils. All bacteria were stained
in red (2) and in green (3). But, no bacteria were colored in green (3) only indicating
that H. pylori was not phagocytosed by murine wt neutrophils. In contrast, humanized
CEACAM1, 3 and 6 PMNs (B, C) showed binding of many H. pylori (green with orange
dots) and a high amount of green fluorescence (3) inside the cells. Inside of the cell only
green fluorescence (3), but no red fluorescence (2) was detected. This demonstrates that
the bacteria were phagocytosed by humanized hCEACAM1, 3 and 6 PMNs.
In addition, to show that H. pylori is located within the cell, reconstructions of the
micrographs were performed using the imaris software (see Fig. 3.11).
A B C
10 µm 10 µm 10 µm
Fig. 3.11: Reconstructions of confocal microscopy images of PMNs infected with H. pylori
Micrographs of confocal microscopy of murine (A) and humanized hCEACAM1, 3, 6 (B, C) neutrophils
infected with H. pylori were rendered in 3D.
The reconstructions of the confocal microscopy images clearly show H. pylori (green) (see
red arrows) inside of humanized neutrophils, but not in wt neutrophils. Taken together,
the confocal microscopy confirmed the flow cytometry and survival assay data.
3.1.7 The role of human CEACAMs on CagA translocation and
phosphorylation
A key event in the infection process of H. pylori is the translocation and subsequent phos-
phorylation of CagA resulting in an activation of CagA inside the host cell. Thus, human,
murine and humanized neutrophils were infected with H. pylori and an immunoblot of
the infected cells (Fig. 3.12 A, B) using CagA and phosphotyrosine antibodies was per-
formed. In addition, in vitro phosphorylation of CagA from cell lysates of infected murine
neutrophils (Fig. 3.12 C) was performed and tested by an immunoblot. Furthermore,
the CagA translocation was quantified with a β-lactamase dependent reporter system by
flow cytometry (Fig. 3.12 D). For this, human, murine and humanized neutrophils were
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infected with a P12 TEM-CagA, a P12 ∆cagI TEM-CagA and a P12 ∆hopQ TEM-CagA
H. pylori strain and were stained with CCF4. Cells containing translocated CagA show
a blue and green fluorescence.
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Fig. 3.12: CagA phosphorylation and quantification of CagA translocation in human,
murine and humanized PMNs
A, B) Immunoblot analysis of CagA phosphorylation in PMNs using α-CagA (AK299) and α-
phosphotyrosine (PY99) antibodies.
A) Human and murine PMNs
B) CEACAM humanized PMNs
C) Immunoblot analysis of the in vitro phosphorylation of CagA in cell lysates of murine PMNs.
D) Quantification of TEM-CagA translocation in PMNs. CagA translocation was studied using a β-
lactamase dependent reporter system. Shown are mean values of the ratio of blue and green fluorescence
of at least three independent experiments normalized to the translocation deficient strain H. pylori P12
∆cagI TEM-CagA. Error bars show the SEM. Statistical analysis was performed using two way ANOVA,
with a Bonferroni post hoc test with * < 0.05, ** < 0.01, *** < 0.001. All bars over the dashed blue line
are positive for CagA translocation.
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The immunoblot analysis detected a 40 kDa phosphorylated fragment of CagA (see Fig.
3.12 A, left side, black arrow) as a result of an infection of human PMNs with P12. This
shows that CagA is translocated in human PMNs and is completely cleaved into a phos-
phorylated C-terminal 40 kDa CagA fragment, because no phosphorylated full length
CagA (135 kDa) was detected. In human neutrophils infected with P12 ∆hopQ or P12
∆cagI (phosphorylation deficient control) no phosphorylated CagA could be detected.
In contrast to human PMNs, murine PMNs infected with P12 did not show CagA phos-
phorylation (see Fig. 3.12 A, right side). However, in all murine neutrophils expressing
human CEACAMs infected with P12 a full length (135 kDa) and a cleaved (40 kDa)
phosphorylated CagA band was detected (see Fig. 3.10 B black arrows). In these cells
CagA is not completely cleaved in 40 kDa fragments. Taken together, the CagA phos-
phorylation and cleaving of CagA (processing) in human and humanized neutrophils is
mediated by CEACAMs. In addition this finding is supported by the fact that no CagA
phosphorylation was seen in an infection of humanized PMNs with P12 ∆hopQ strain
(see Fig. 3.12 B).
Notably, CagA is not phosphorylated in murine PMN infected with P12 (see Fig. 3.12
A). To prove, whether kinase are active in murine neutrophils, an in vitro phosphoryla-
tion assay was performed. In cell lysates of murine PMNs full length CagA (135 kDa) is
phosphorylated (see Fig. 3.12 C). Consequently, host kinases are active in murine PMNs.
This leads to the question, whether CagA is translocated into murine PMNs.
Quantification of CagA translocation revealed that CagA is translocated in all different
PMNs, even in murine wt PMNs (see Fig. 3.12 D, gray bar). However, the amount of
CagA in hCEACAM1, 3, 6 neutrophils (purple bar) was three times and in hCEACAM1
(red bar) and hCEACAM3, 6 (turquoise bar) two times higher in comparison to human
(black bar) and murine (gray bar) neutrophils. This indicates that CagA is translocated
into murine PMNs, but not phosphorylated or rapidly dephosphorylated. The CEACAM
effect in CagA translocation was supported by a two to three times reduced CagA translo-
cation in humanized neutrophils infected with P12 ∆hopQ TEM-CagA. Furthermore, this
is consistent with the result that murine neutrophils without human CEACAMs showed
no HopQ dependent reduction in CagA translocation. In addition, consistent with human-
ized neutrophils, the CagA translocation in human neutrophils was reduced depending
on HopQ.
In conclusion, these results demonstrate that CagA is translocated in all different types of
PMNs. But, human CEACAMs are necessary to enable CagA phosphorylation and pro-
cessing of CagA in PMNs. This demonstrates the physiological relevance of CEACAMs.
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3.1.8 Influence of SHP-1 on CagA phosphorylation
Although, CagA is translocated into murine PMNs, and it was proven that host kinases
are active in murine PMNs (see section 3.1.7 C, D), no phosphorylated CagA was ob-
served in murine PMNs. It is known, that CagA interacts with different proteins in the
host cell (see section 1.2.3). Saju et al. could show that phosphorylated CagA interacts
with SHP-1 and SHP-2. SHP-2 enhance the oncogenicity of CagA, whereas SHP-1 damp-
ens the oncogenicity of CagA by dephosphorylation of its EPIYA motifs [52].
Thus, SHP-1 was blocked in murine PMNs using two different inhibitors sodium stiboglu-
canat or hydrogen peroxide and an infection experiment, followed by an immunoblot
analysis using CagA and phosphotyrosine antibodies was performed (see Fig. 3.13).
A B
murine PMNs murine PMNs
sodium stiboglucanat
murine PMNs murine PMNs
hydrogen peroxide
Fig. 3.13: Chemical inhibition of SHP-1 in murine PMNs
CagA phosphorylation in infected PMNs with an inhibition of SHP-1 either with sodium stiboglucanat
(A) or hydrogen peroxide (B) was analyzed in an immunoblot.
Inhibition of SHP-1 using either sodium stiboglucanat or hydrogen peroxide did not result
in detection of phosphorylated CagA in murine PMNs.
As inhibition of SHP-1 seems to have no influence on CagA phosphorylation in murine
PMNs, the possible effect of CEACAM1 in combination with SHP-1 on CagA phosphory-
lation was analyzed. It is known that CEACAM1 in its dimerized form can recruit SHP-1
via its ITIMs, which subsequently are phosphorylated by Src kinases [107]. Bonsor et
al. could show that HopQ can inhibit CEACAM1 dimerization (see section 1.4.6) [38].
A possible mechanism could be that SHP-1 recruited to dimerized CEACAM1 could de-
phosphorylate CagA, whereas HopQ interrupts the CEACAM1 dimerization and SHP-1
signaling and CagA is not dephosphorylated. To analyze this aspect further, SHP-1 was
deleted in a murine neutrophil cell line expressing human CEACAMs using the CRISPR
Cas9 technology (see section 2.7). Moreover, murine CEACAM1 was deleted in the same
cell line to avoid negative influences of both murine and human CEACAM1 in combina-
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tion. For these experiments, the MPRO neutrophil cell lines expressing human CEACAMs
was used, which was kindly provided by Prof. Dr. Scott Gray Owen [113]. Phosphory-
lation of CagA was determined in an immunoblot analysis of the generated cells infected
with P12 wt (see Fig. 3.14).
IB: α- P-Tyr
strainfree
IB: α- P-Tyr
1
A
2 c 4
1 = MPRO ∆SHP-1
2 = MPRO hCEACAM3 ∆SHP-1
c = control human PMNs (left: uninfected, right: infectd with P12 wt)
3 = MPRO hCEACAM1 ∆SHP-1
4 = MPRO hCEACAM1 ∆mCEACAM1, ∆SHP-1
(except controls all cells were infected with P12 wt)
3
135 kDa
40 kDa
c
Fig. 3.14: Immunoblot analysis of different MPRO cells with a deletion in SHP-1
SHP-1 was deleted in MPRO, MPRO hCEACAM1 and MPRO hCEACAM3 cells using the CRISPR
Cas9 technology. Moreover, murine CEACAM1 was deleted in MPRO CEACAM1 cells. Cells with SHP-
1 and/or murine CEACAM1 deletion were infected for 3 h with an MOI of 60 with H. pylori P12. Then,
an immunoblot was performed analyzing phosphorylation.
However, a SHP-1 deletion in MPRO, MPRO hCEACAM3 and MPRO hCEACAM1 cells
as well as an additional deletion of murine CEACAM1 did not result in CagA phospho-
rylation in murine neutrophils. Therefore, further experiments have to be performed to
understand this phenomenon in the future.
3.1.9 2D migration of murine and humanized PMNs
Next, to study whether the expression of human CEACAMs influence 2D migration of
neutrophils, an under agarose assay was performed using LTB4 as a chemoattractant,
which should result in swarming of neutrophils (see Fig. 3.15). In vivo, PMNs use
chemoattractant gradients to find their way to the site of infection (see section 1.1.2).
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Fig. 3.15: 2D migration of murine and humanized PMNs
Murine or humanized PMNs were filled in one slot of an agarose gel and in another slot the chemoat-
tractant LTB4. After 1 h, the chemoattractant gradient was formed and migration was studied using
time-lapse microscopy. Error bars show the SEM of two independent experiments.
A-D) Plots showing the migration of PMNs
A) murine B) hCEACAM1 C) hCEACAM3, 6 D) hCEACAM1, 3, 6
E) Quantification of the velocity of migration
F) Quantification of the migrated distance
The plots of the 2D migration assay illustrate that murine as well as humanized neu-
trophils swarmed towards the chemoattractant LTB4 (see Fig. 3.15 A-D). In this regard
the humanized cells do not show differences compared to murine wt PMNs. To further
prove this observation, the velocity (Fig. 3.15 E) and distance (F) of swarming towards
the chemoattractant LTB4 was quantified. Consistent with the results of the plots the
swarming did not differ significantly between the cells. This indicates that CEACAM
expression does not influence the migration behavior towards LTB4. However, further
chemoattractive substances have to be tested in the future. Besides migrating towards a
chemoattractant gradient to the site of infection or inflammation, neutrophils themselves
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are able to secrete chemical attractants to recruit further immune cells.
3.2 The role of human CEACAMs on the secretion
of chemokines
3.2.1 Chemokine secretion of PMNs infected with H. pylori
In a further experiment the chemokine secretion of neutrophils was studied with a bead
based sandwich immunoassay (see Fig.3.16).
R
A
N
TE
S 
M
IP
-3
E
ot
ax
in
TA
R
C
K
C
M
C
P-
1
M
IG
IP
-1
0 
M
IP
-1

M
IP
-1 B
LC LI
X
M
D
C
0
100
200
300
400
500
600
***
***
***
***
***
c
o
n
c
e
n
tr
a
ti
o
n
[p
g
/m
l]
K
C 
M
IP
-1

M
IP
-1 LI
X
0
100
200
300
400
500
600 *** ***
******
***
c
o
n
c
e
n
tr
a
ti
o
n
[p
g
/m
l]
Overview
murine uninfected
murine infected
murine LPS
hCEACAM1, 3, 6 uninfected
hCEACAM1, 3, 6 infected
hCEACAM1, 3, 6 LPS
A
B
Fig. 3.16: Chemokine secretion of PMNs infected with H. pylori
Murine and hCEACAM1, 3, 6 PMNs were infected with H. pylori with an MOI of 60. As a control
PMNs were incubated with LPS or uninfected. After 3 h the supernatant of the infection was collected.
Chemokine concentrations of two replicates of two independent experiments of murine wt PMNs and four
independent experiments of humanized PMNs were determined using the Legendplex proinflammatory
chemokine panel 13 plex by flow cytometry. Error bars show the SEM. The statistics were analyzed using
two way ANOVA, with a Bonferroni post hoc test, * p < 0,05, ** p < 0,01, *** p < 0001.
A) Overview of all 13 different chemokines
B) KC, MIP-1α, MIP-1β, LIX concentrations
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Figure 3.16 shows the chemokine concentrations in supernatants of murine or humanized
neutrophils infected with H. pylori for 3 h, incubated with LPS or uninfected to ver-
ify whether CEACAMs influence the physical behavior of neutrophils in an inflammatory
response. The chemokine measurement of infected neutrophils detected MIP-1β and MIP-
1α in a high concentration (see Fig. 3.16 A). Scapini et al. could show that human PMNs
secrete IL-8, Groα, MIP-1α, MIP-1β, IP-10 and MIG. Functionally homologes of IL-8
and Groα in the murine organism are KC, MIP2 and LIX. MIP2 was not analyzed in this
thesis. KC and LIX were detected in this experiments only in very low concentrations,
whereas MIP-1β was found in low and MIP-1α in high concentrations. IP-10 and MIG
could not be detected in these experiments, because IP-10 and MIG need a costimulation
with IFN-γ in combination with LPS or TNF-α, as it was shown by Gasperini et al. [17].
The concentration of MIP-1α in humanized PMNs (purple) was increased 2.5 times com-
pared to murine wt neutrophils (gray) (see Fig. 3.16 B). An incubation with LPS (blue)
increased the amount of MIP-1α secreted by murine wt PMNs. This concentration of
MIP-1α after LPS stimulation was similar to humanized PMNs incubated with LPS.
However, humanized neutrophils infected with H. pylori secreted 1.7 times more MIP-1α
than neutrophils incubated with LPS. The function of secreted MIP-1α is the recruitment
of further immune cells to the site of infection. Here, the secretion of MIP-1α in high
concentrations indicates an enhanced proinflammatory response initiated by humanized
neutrophils, which might influence the pathology in an infection with H. pylori. More-
over, it highlights the role of CEACAMs on neutrophils in the interaction with H. pylori.
Furthermore, this result raises the question, whether the CEACAM expression also has
an effect on cells recruited by neutrophils like DCs and MΦ.
3.2.2 Chemokine secretion of DCs and MΦ infected with H.
pylori
Similar to murine and humanized neutrophils chemokine secretion was measured in su-
pernatants of murine and humanized DCs and MΦ, which were infected with H. pylori
(see Fig. 3.17).
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Fig. 3.17: Chemokine secretion of DCs and MΦs infected with H. pylori
Murine DCs (A) and MΦs (B) and humanized DCs (A) and MΦs (B), expressing human CEACAM1, 3
and 6 were infected with H. pylori with an MOI 60 for 3 h. Afterwards, the supernatant was collected.
Chemokine concentrations of two replicates of three independent experiments were measured with the
Legendplex proinflammatory Chemokine panel 13 plex by flow cytometry. Error bars show the SEM.
Statistical analysis was performed using ANOVA, Two way, with a Bonferroni post hoc test, * p< 0,05,
** p< 0,01, *** p<0001
DCs infected with H. pylori release KC in high and MIP-1α in moderate concentrations
(see Fig. 3.17 A). However, the secretion seems to be independent of CEACAMs, be-
cause murine (gray bar) and humanized (purple bar) DCs release the same amount of
KC and MIP-1α. The function of KC is the recruitment of neutrophil, whereas MIP-
1α attracts DCs. The amount of MIP-1α produced from murine DCs is comparable to
murine neutrophils (see Fig. 3.17 A). However, humanized DCs secrete only half of the
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amount of MIP-1α compared to humanized neutrophils. Furthermore, DCs produce other
chemokines independent of an infection with H. pylori like TARC and MDC in high con-
centrations and RANTES, IP-10 and LIX in low concentrations.
Infected MΦ secrete high concentrations of KC and IP-10 (see Fig. 3.17 B). As already
mentioned, the function of KC is the attraction of neutrophils, whereas IP-10 recruits
T-cells. Furthermore, MΦ release moderate concentrations of MCP-1 and MDC and low
concentrations of MIP-1α, MIP-1β, LIX and, independent of the infection with H. pylori,
TARC. KC is significantly down regulated in humanized MΦ (see Fig. 3.17, purple bar)
compared to murine MΦ (gray bar). Moreover, MCP-1 was downregulated in humanized
MΦ compared to murine MΦ. The opposite phenomenon was seen in MDC. There, the
MDC secretion was upregulated in humanized MΦ compared to murine MΦ. However,
the differences in production of MCP-1 and MDC are not significant. The amount of
MIP-1α was five times lower compared to humanized neutrophils (see Fig. 3.16).
All in all, it seems that the chemokine secretion of infected DCs and MΦ is mostly in-
dependent of CEACAMs. In comparison to neutrophils CEACAMs do not influence the
chemokine secretion of immature DCs and MΦ. One exception is the release of KC, which
was lower in humanized MΦ in comparison to murine wt MΦ. So, these data support the
special role of CEACAMs on neutrophils in the proinflammatory response. However, so
far only the proinflammatory response was analyzed. Thus, the role of CEACAMs in the
interaction of H. pylori with DCs or MΦ was further investigated.
3.3 Interaction of H. pylori with DCs and MΦ
Neutrophils recruit DCs and MΦ to the site of infection. In the previous section it was
already shown that chemokine secretion of DCs and MΦ infected with H. pylori was not
strongly influenced by CEACAMs. In the following section the CEACAM expression, the
interaction with H. pylori and the CagA translocation and phosphorylation in DCs and
MΦ were studied. This is important to verify, whether the CEACAM effect is unique for
neutrophils or not.
3.3.1 CEACAM expression of DCs and MΦ
First DCs and MΦ were characterized and their CEACAM expression was analyzed by
flow cytometry as it was described before for isolated neutrophils (see Fig. 3.18).
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Fig. 3.18: Characterization and CEACAM expression of DCs and MΦ
DCs and MΦ were characterized by flow cytometry using the following antibodies: CD11c PE anti mouse,
PE-Cy5 conjugated with F4/80 and the isotype controls PE rat IgG2a and rat IgG2a PE-Cy5. Graphs
show one representative experiment. CEACAM expression was analyzed using the following antibodies:
CEACAM1 (3/4/17, Genovac), CEACAM3 (col-1, Thermo Fisher), CEACAM6 (9A6, Genovc) and a
ALEXA488 conjugated secondary antibody (isotype control). Moreover, CEACAM expression was quan-
tified (see C-E). All bars over the dashed blue line show CEACAM expression. Statistics was performed
using Two way ANOVA, with a Bonferroni post hoc test. The error bars show the SEM of at least three
independent experiments, * < 0.05, ** < 0.01, *** < 0.001.
A) Murine bone marrow derived DCs
B) Murine bone marrow derived MΦ
C-E) Quantification of CEACAM expression
DCs showed a positive signal for CD11c and MΦ for F4/80 (see Fig. 3.18). Thus, both
expressed their characteristic cell surface markers. Generally, the CEACAM expression
levels were low on DCs and MΦ. Human and humanized DCs expressed low levels of
human CEACAM6. In humanized DCs the amount of CEACAM6 expression was a bit
higher compared to human DCs. Human and humanized MΦ did not differ in their CEA-
CAM expression levels. Both expressed very low levels of CEACAM1 and 6. In total,
CEACAM expression of naive DCs and MΦ was very low compared to human and hu-
manized neutrophils (see section 1.1.1).
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3.3.2 Interaction of H. pylori with DCs and MΦ
Next, the interaction of H. pylori with DCs and MΦ was analyzed (see Fig. 3.19).
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Fig. 3.19: Interaction of H. pylori with DCs and MΦ
The interaction was analyzed after an infection for 1 h with an MOI of 10 using a P12 GFP (black
bars) or a P12 ∆hopQ GFP mutant strain (gray bars) or left uninfected (white bar) by flow cytometry.
Statistics was performed using Two way ANOVA, with a Bonferroni post hoc test. The error bars show
the SEM, * < 0.05, ** < 0.01, *** < 0.001.
Human DCs and MΦ infected with P12 wt (see Fig. 3.19, black bars) show an increased
fluorescence intensity compared to murine and humanized cells. However, the fluorescence
intensity of human DCs is three times higher compared to human MΦ. The difference
between human and murine cells indicates a CEACAM effect in DCs and MΦ. This effect
is supported by a reduced fluorescence intensity in an infection with the P12 ∆hopQ
mutant strain (gray bar).
Murine and humanized DCs as well as MΦ interact independently of CEACAMs with
the bacterium, because an infection of human DCs and MΦ with the P12 ∆hopQ mutant
strain (gray bar) does not results in a reduced fluorescence intensity compared to an
infection with P12. Generally, murine and humanized DCs show a low interaction with
H. pylori after 1 h infection and the interaction of murine and humanized MΦ is even
lower. All in all, the interaction of H. pylori with DCs or MΦ is three to four times lower
compared to neutrophils (see Fig. 3.4).
3.3.3 CagA translocation and phosphorylation
The translocation and subsequent phosphorylation of CagA are associated with a more
serious progression of an H. pylori infection (see section 1.2.3). In this work it could be
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shown, that CagA is not phosphorylated in murine PMNs, but in murine PMNs expressing
human CEACAMs (see Fig. 3.12). Thus, the CagA translocation and phosphorylation in
DCs and MΦ was analyzed (see Fig. 3.20).
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Fig. 3.20: CagA phosphorylation and quantification of CagA translocation in human,
murine and humanized DCs and MΦ
A, B) Immunoblot analysis of CagA phosphorylation in human, murine and humanized DCs and MΦ.
Cells were infected for 3 h with an MOI of 60 with H. pylori P12, P12 ∆hopQ and P12 ∆cagI.
A) Human, murine and humanized DCs
B) Human, murine and humanized MΦ
C) Quantification of TEM-CagA translocation in DCs. CagA translocation was studied using a β-
lactamase dependent reporter assay. Graphs displays mean values of the ratio of blue to green
fluorescence of at least three independent experiments normalized to the translocation deficient strain
H. pylori P12 ∆cagI TEM-CagA. Error bars show the SEM of at least three independent experiments.
Statistical analysis was performed using two way ANOVA, with a Bonferroni post hoc test with * <
0.05, ** < 0.01, *** < 0.001. All bars over the blue dashed line are positive for CagA translocation.
D) Fluorescence microscopy of DCs and MΦ infected with H. pylori P12 TEM-CagA and stained with
CCF4
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CagA is phosphorylated in human, murine and humanized DCs and MΦ (see Fig. 3.20
A and B). MΦ showed a stronger CagA phosphorylation compared to DCs. However,
CagA phosphorylation in MΦ is independent of CEACAMs, because similar amounts of
phosphorylated CagA were detected in cells infected with the P12 ∆ hopQ mutant strain.
Quantification revealed that CagA is translocated in human, humanized and murine DCs
(see Fig. 3.20 C). Human (black) and humanized (purple) DCs show a higher amount of
translocated CagA in comparison to murine (gray) DCs. Again, compared to neutrophils
the amount of translocated CagA is much lower in DCs. CagA translocation could not
be detected in MΦ using the β-lactamase dependent reporter assay, as no signal can be
detected. To study this, microscopy of the cells infected with H. pylori P12 TEM-CagA
and labeled with CCF4 was performed. Fig. 3.20 D shows green fluorescent DCs, whereas
MΦ exhibit no fluorescence.
Taken together, CEACAMs do not influence CagA translocation and phosphorylation in
humanized DCs and MΦ. These data highlight the special role of CEACAMs on neu-
trophils in the interaction with H. pylori.
3.4 Impact of a chronic infection with H. pylori on
the interaction with neutrophils
Finally, it was evaluated whether human CEACAMs on neutrophils have an effect in
vivo, too. Thus, it was analyzed whether neutrophils from humanized mice, which were
chronically infected with H. pylori, show a different behavior compared to neutrophils
from humanized naive mice. Murine wt neutrophils of naive and chronically infected mice
were used as controls. It was known before, that pre- and coinfections of H. pylori reduce
the amount of CagA translocation in host cells [159].
3.4.1 Effect on CagA translocation and phosphorylation
Firstly, the CagA translocation into neutrophils from chronically infected mice was stud-
ied. Therefor, mice were infected for four weeks with the mouse adapted H. pylori strain
PMSS1. Afterwards, neutrophils were isolated and used in translocation experiments (see
Fig. 3.21).
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Fig. 3.21: Translocation of CagA into neutrophils isolated from chronically infected mice
CagA translocation was quantified using the β-lactamase dependent reporter assay. Before, mice were
infected for four weeks with the H. pylori PMSS1 strain. Afterwards, neutrophils were isolated and then,
a translocation assay was performed. Shown are mean values of the ratio of blue to green fluorescence
of at least three independent experiments normalized to the translocation deficient strain H. pylori P12
∆cagI TEM-CagA . Error bars show the SEM. Statistical analysis was performed using Two way ANOVA,
with a Bonferroni post hoc test with * < 0.05, ** < 0.01, *** < 0.001.
After an infection with H. pylori P12 TEM-CagA a significantly reduced amount of CagA
was detected in humanized hCEACAM1, 3, 6 neutrophils from chronically infected mice
(see Fig. 3.20, pink bar) in comparison to neutrophils from naive mice (purple). In
murine wt neutrophils (gray) from chronically infected mice (white) a low reduction of
CagA translocation can be seen. A reduced amount of CagA translocation was also seen
in an infection with P12 ∆hopQ TEM-CagA. This indicates that H. pylori changes its
behavior towards PMNs coming from an infected host. This result suggests that there
might be a difference between naive and chronically infected PMNs and that the bacterium
can distinguish between both.
Therefore, it was further analyzed whether the effect could be seen in human neutrophils
as well (see Fig. 3.22). Moreover, it was studied whether human CEACAM1 plays a
special role in this context (see Fig. 3.20), as previous results from phagocytosis survival
assay suggest (see section 3.1.4).
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Fig. 3.22: Translocation of CagA into neutrophils isolated from naive versus chronically
with H. pylori infected humans
CagA translocation was quantified with the β-lactamase dependent reporter assay by flow cytometry.
For this, neutrophils were isolated from blood of naive as well as chronically infected individuals without
symptoms. Afterwards, a translocation assay was performed. Shown are mean values of the ratio of blue
to green fluorescence of at least three independent experiments normalized to the translocation deficient
strain H. pylori P12 ∆cagI [TEM-CagA] . Lighter colors show the chronically infected neutrophils. Error
bars show the SEM. Statistic analysis was performed using Two way ANOVA, with a Bonferroni post
hoc test with * < 0.05, ** < 0.01, *** < 0.001.
In human neutrophils (black) isolated from blood of chronically infected individuals (dark
gray) without symptoms a weak reduction in CagA translocation was revealed in com-
parison to human neutrophils of naive individuals (darker hue). An infection of human
chronically with H. pylori infected individuals with the P12 ∆hopQ TEM-CagA strain
shows a reduction in CagA translocation in comparison to P12 wt. Notably, neutrophils
of chronically infected mice expressing only human CEACAM1 (red) infected with P12
TEM-CagA did not show a reduced CagA translocation as it was seen for chronically
infected hCEACAM1, 3, 6 PMNs. The amount of CagA of these chronically infected
hCEACAM1 PMNs is similar to neutrophils of naive mice expressing only human CEA-
CAM1 (red). This again highlights a special role of human CEACAM1.
Further, it was evaluated whether a chronic infection also has an effect on CagA phos-
phorylation (see Fig. 3.23).
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Fig. 3.23: CagA phosphorylation in neutrophils from naive versus chronically with H.
pylori infected individuals
Immunoblot analysis of neutrophils infected with H. pylori from a naive person and a chronically with
H. pylori infected person.
In human PMNs of naive and chronically infected individuals CagA phosphorylation was
detected. The CagA band of the chronically infected individuals is stronger as com-
pared to the CagA band of the naive individuals. Moreover, neutrophils from chronically
infected individuals show a weak CagA phosphorylation band in an infection with the
P12 ∆hopQ mutant strain, indicating differences between naive and chronically infected
PMNs.
3.4.2 Effect on CEACAM expression
Consequently, the expression of CEACAMs in chronically infected murine, human and
humanized neutrophils was analyzed (see Fig. 3.24).
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Fig. 3.24: CEACAM expression of neutrophils from naive and chronically infected humans
CEACAM expression was studied by flow cytometry using the following antibodies: α-CEACAM1
(4/3/17), α-CEACAM3 (col-1) und α-CEACAM6 (9A6).
A) The graphs show a representative experiment CEACAM1 (red), CEACAM3 (green), CEACAM6
(blue) and isotype control (beige).
B) Quantitative analysis of CEACAM expression normalized to isotype control. Error bars show the SEM
of at least three independent experiments. Statistical analysis was performed using Two way ANOVA,
with a Bonferroni post hoc test with * < 0.05, ** < 0.01, *** < 0.001.
Naive PMNs (darker hue) express a significantly higher level of CEACAM1 (Fig. 3.24 B)
and CEACAM6 (C) as compared to PMNs of chronically infected (lighter hue) humanized
neutrophils. But, in human neutrophils the CEACAM1 and 6 expression was significantly
higher in neutrophils of chronically infected individuals.
These data suggest that a CEACAM effect is also seen under in vivo infection conditions.
Moreover, they show that H. pylori is able to manipulate neutrophils. All in all, it could
be shown that human CEACAMs on neutrophils can drastically influence the interaction
with H. pylori.
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4. Discussion
Today, the interaction of CEACAMs with more than ten different pathogens such as E.
coli, H. influenzae, H. pylori, N. gonorrhoeae, N. meningitidis, M. catarrhalis, and differ-
ent Salmonella strains [96], [97], [34], [98], [99], as well as human pathogenic fungi such as
Candida albicans [100] are known. All started in 1965 with the discovery of CEA, which
was found overexpressed in tumor tissue. To establish an animal model for tumor im-
munotherapy, transgenic CEA mice expressing human CEACAM5 were generated [137].
At that time it was already known that binding to host cells is a key event in the infection
process of bacteria [160], [161]. In addition, in vitro experiments showed that bacteria
such as N. gonorrhoeae bind via its Opa proteins to CEACAMs expressed on epithelial
cells as well as on neutrophils [114], [162], [163]. The Gram-negative bacterium N. gon-
orrhoeae colonizes the mucosa of the human urogenital tract, which is characterized by
massive infiltration of neutrophils and can cause gonorrhoea. In 2005, in vitro studies
demonstrated that bacteria such as N. gonorrhoeae induce detachment of epithelial cells
[164], as a reaction of the innate immune response. To study the role of CEA in vivo
Muenzer et al. worked with transgenic CEA mice. They discovered that N. gonorrhoeae
interact with CEA resulting in colonization of the urogenital tract of transgenic CEA
mice after 24 h of infection, whereas wild-type mice were not colonized [164]. The bac-
teria suppress exfoliation by triggering de novo expression of CD105, which blocks cell
migration and promotes adhesion [165].
The transgenic CEA mice were also used for an infection with H. pylori, which is a Gram-
negative, mucus-associated human pathogen like N. gonorrhoeae. Koeniger et al. studied
the interaction of H. pylori with CEACAMs on epithelial cell lines in vitro as well as in the
transgenic CEA mice expressing CEACAM5 in vivo. For H. pylori it was shown that its
adhesin HopQ interacts with human CEACAM1, 5 and 6 on epithelial cells [34]. However,
HopQ is not able to recognize murine CEACAMs [34]. The role of human CEACAMs for
the interaction of H. pylori with neutrophils was not studied so far.
Massive infiltration of neutrophils is a hallmark of a H. pylori infection as well as an
infection of N. gonorrhoeae. But, the PMNs and the corresponding immune response are
manipulated by H. pylori as well as N. gonorrhoeae and the immune system cannot clear
the infection. Instead inflammation occurs, which can result in case of H. pylori in MALT
lymphoma and stomach cancer.
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To learn more about the role of CEACAMs and to create a model system to study human
pathogens binding to CEACAMs such as N. gonorrhoeae in vivo, Chan et al. included
a CEABAC in mice and generated transgenic mice expressing CEACAM3, 5, 6 and 7
[138]. Moreover, Gu et al. generated transgenic mice expressing human CEACAM1 [126].
Islam et al. used these transgenic CEACAM mice and studied the role of CEACAMs in
an infection of N. gonorrhoeae in vivo. They could support the initial findings of Muenzer
et al. by showing that CEACAM5 promotes a long-term colonization of the bacteria in
the lower genital tract [166]. In addition, it was found that human CEACAM1 facilitates
penetration into the tissue [166]. Furthermore, Sintsova et al. demonstrated by in vivo
experiments using the transgenic CEACAM mice that CEACAM-expressing neutrophils
migrate faster to the site of infection, to be activated by N. gonorrhoeae [167]. Together
with the findings of Sarantis et al. defining the role of CEACAM3 as a trigger for phago-
cytosis, CEACAM3 was characterized as a protective as well as pathogenic receptor [113].
For H. pylori it is as well known that the bacterium promotes neutrophils recruitment as
well as it is engulfed by neutrophils. Thus, in this work neutrophils as well as DCs and
MΦ were isolated from the transgenic CEACAM mice to study the role of CEACAMs in
their interaction with H. pylori.
4.1 H. pylori interacts with human CEACAMs to
manipulate neutrophils
It was shown that H. pylori P12, as well as other H. pylori strains, efficiently bind to
neutrophils dependent on their expression of human CEACAMs. These results were sup-
ported by a reduced binding of the ∆hopQ mutant strain lacking the adhesin to interact
with CEACAMs as well as to wt murine PMNs. The CEACAM specific efficient binding
of the bacterium to neutrophils is uniform with the finding of Königer et al. on epithelial
cells [34]. Moreover, it is consistent with the CEACAM specific binding of N. gonorrhoeae
via its Opa proteins to neutrophils [163], [97]. In comparison to several Opa proteins of
N. gonorrhoeae, HopQ is so far the only known counterpart of H. pylori for human CEA-
CAMs and in addition, the expression of HopQ is not phase variable. HopQ interacts with
CEACAMs via the IgV like N-terminal domain and can inhibit dimerization of human
CEACAM1 [38].
CEACAM1 exists in different splice variants. Isoforms of CEACAM1 can form oligomers,
which assemble in microdomains. These microdomains are characterized by the presence
of constant (IgC2-like) domains. In its dimerized form, the receptor can recruit signaling
molecules such as SHP-1 via its ITIMs, which are phosphorylated by Src kinases [107].
Thereby specific signaling pathways such as the PI3K dependent signaling pathways are
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activated. They can trigger events like the de novo expression of CD105 after interaction
of N. gonorrhoeae with CEACAMs and promote adhesion followed by the bacterial colo-
nization [165].
Wildtype mice are neither colonized by N. gonorrhoeae nor by H. pylori. Only a few
adapted strains are able to colonize mice. Interestingly, the mouse adapted strain of H.
pylori called SS1 showed a low CEACAM effect in the interaction with PMNs, whereas
the Mongolian gerbil adapted strain demonstrated a strong CEACAM effect. It is known
that HopQI is down regulated in the SS1 strain [34]. The finding of a lower CEACAM-
dependent binding of the SS1 strain is consistent with the results of Cao et al., describing
an enhanced binding and CagA phosphorylation in strains producing HopQI [127]. An
explanation for the increased binding of the Mongolian gerbil strain on humanized CEA-
CAM PMNs could be the stronger pathology after a H. pylori infection. In Mongolian
gerbils the bacterium can induce intestinal metaplasia, gastric ulcer and adenocarcinoma
(see section 1.5) [132], [133]. The pathology of Mongolian gerbils is more comparable to
humans than the one in mice [135]. But, the stronger CEACAM effect of the Mongolian
gerbil adapted B8 strain in comparison to human H. pylori strains is still an open ques-
tion. Thus, it would be interesting to study the role of neutrophils and CEACAMs in
the Mongolian gerbil. However, the Mongolian gerbil as a model organisms is not well
established so far (see section 1.5) and only little is known about CEACAMs in gerbils.
4.1.1 CEACAMs facilitate survival of phagocytosis
Furthermore, it could be shown that the interaction of H. pylori with CEACAMs enable
the bacterium to modify neutrophils. Binding of H. pylori results in ROS production
and neutrophils try to eliminate the bacteria by phagocytosis. However, H. pylori resists
clearance, because of the active manipulation of immune cells by the bacterium. Notably,
H. pylori actively recruits neutrophils, which should kill the bacterium, via several factors
such as HP-NAP, SabA as well as the T4SS encoded on the Cag-PAI [72], [41]. It is
already known that H. pylori developed mechanisms to avoid phagocytosis. Allen et al.
reported that H. pylori disrupts the NADPH oxidase and thereby avoids killing by PMNs
[60]. Ramarao et al. described that the bacterium possesses an active antiphagocytic
activity in PMNs and MΦ involving de novo protein synthesis by the bacterium and the
T4SS [71]. But, it was not known so far whether and how CEACAMs are involved in these
processes. In this work it was shown for the first time that H. pylori survives phagocytosis
via the interaction with CEACAM3 and/or 6 and can not be eliminated by neutrophils.
These data are consistent with a higher ROS production in these cells, because disruption
of NADPH oxidase results in cell damage and ROS release. Moreover, phagocytosis of
neutrophils is a fast process leading to the occurence of incomplete phagosomal matura-
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tion, which also causes the release of ROS [20].
For other bacteria such as N. gonorrhoeae, H. influenzae, M. catarrhalis it was as well
described that after binding to CEACAMs they are engulfed by neutrophils going along
with a strong oxidative burst [116], [168]. However, after binding to CEACAM3 these
bacteria are rapidly killed by the intracellular oxidative burst [169]. H. pylori survives
after binding to CEACAM3 and/or 6 on neutrophils, as it could be shown in this work.
Notably, it was demonstrated that hCEACAM1 neutrophils act contrary in ROS produc-
tion and that the bacteria do not survive phagocytosis in hCEACAM1 PMNs. In addition,
the survival of the bacterium in PMNs expressing CEACAM1, 3 and 6 was reduced in
comparison to neutrophils expressing only CEACAM3 and 6. Human CEACAM1 con-
tains two ITIMs. In B- and T cells CEACAM1 has an inhibitory function because of
these ITIMs [101]. Boulton et al. demonstrated that binding of N. gonorrhoeae to human
CEACAM1 leads to inhibition of the CD4+ T-cell response via the ITIM [101]. Boul-
ton et al. also showed that CEACAM1 can be phosphorylated in PMNs. In addition,
infection of M. catarrhalis and N. meningitidis by binding to human CEACAM1 inhibit
the TLR2 initiated transcription factor NF-κB and prevent the TLR2 initiated immune
response [102]. An inhibitory effect of human CEACAM1 on neutrophils is so far un-
known. The results of this work indicate that H. pylori may avoid the inhibitory function
of CEACAM1 on neutrophils and probably acts on CEACAM3 and 6.
For CEACAM3, which is exclusively expressed on neutrophils, it is known, that it has
an influence on ROS production and phagocytosis [116]. Contrary to the survival of H.
pylori in CEACAM3 and 6 PMNs, it is described that CEACAM3 can direct opsonin
independent phagocytosis of Neisseria, Moraxella and Haemophilus species [116]. In ad-
dition, Sarantis et al. showed that after bacterial binding to CEACAM3, the cytoplasmic
tyrosine kinase (spleen tyrosine kinase (Syk)) is recruited and phosphorylates the ITAM
of CEACAM3, which is necessary for an efficient killing process [170]. Moreover, in the
process of phagocytosis of N. gonorrhoeae triggered by CEACAM3 the actin cytoskele-
ton is completely reorganized regulated by the small GTPases Rac1 and Cdc42, but not
Rho, while CEACAM1 and 6 engulfment do not require changes in the actin cytoskele-
ton [171]. However, in vitro experiments show that engulfment of N. gonorrhoeae by the
human myelomonocytic cell line JOSK-M expressing human CEACAM1, 6 activates a sig-
nalling cascade from CEACAMs via Src-like protein tyrosine kinases, Rac1 and PAK to
Jun-N-terminal kinase [172]. Moreover, they demonstrated that Inhibition of Src-kinases
or Rac1 protects the bacteria from phagocytosis [172].
A possible mechanism to support survival of H. pylori after phagocytosis in PMNs ex-
pressing CEACAM3 and 6 could be a manipulation of the signaling cascade by interfering
with the ITAM motif of CEACAM3 by H. pylori, to avoid activating signals. It was shown
in this work that human CEACAMs enable CagA phosphorylation, probably by changing
signaling cascades. However, in this project it was not possible to distinguish between
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CEACAM3 and 6. CEACAM3 is expressed in the transgenic CEABAC mouse [138], but,
expression is low and was only detected in very low levels in this work. Thus, also CEA-
CAM6 or a combination of CEACAM3 and 6 can be the reason for the differences. It is
known that CEACAM6 promotes formation of tumors [103]. But its role during pathogen
interaction is so far unknown. Thus, in future experiments it will be important to use cell
lines or mice which allow distinguishing between CEACAM3 and 6.
In addition, it could be shown that a deletion of CagA and especially of VacA decreased
the survival of phagocytosis in hCEACAM3, 6 PMNs. Moreover, H. pylori strains without
VacA show a reduced survival rate in hCEACAM1, 3, 6 PMNs. Survival of the bacterium
in PMNs is probably a failure of the killing process of PMNs. A hallmark of phagocytosis
of neutrophils is the high speed of the phagocytosis process, which can result in incom-
plete phagosomal maturations [20]. Already Allen et al. reported that VacA is involved
in retarding phagocytosis of H. pylori by MΦ [60]. They discovered that VacA and urease
disrupt membrane trafficking and inhibit phagosome-lysosome fusion in MΦ [173]. More-
over, Zheng et al. could show that VacA is important for the disruption of phagosome
maturation by recruiting coronin1 in MΦ [174]. However, work by Odenbreit et al. and
Rittig et al. did not notice differences between H. pylori strains with or without VacA
for phagocytosis by MΦ [152], [175]. Taken together, the data of this project confirm the
data of Allen et al. and Zheng et al. that VacA is involved in survival of phagocytosis. In
addition, survival of phagocytosis might be less important for H. pylori strains without
CagA and VacA, because they induce a weaker response of the immune system resulting
in less phagocytosis and inflammation [176].
4.1.2 CEACAMs enable CagA phosphorylation in PMNs
Besides the involvement of CEACAMs in survival of phagocytosis as already mentioned
it was shown that human CEACAMs enable CagA phosphorylation in murine PMNs.
CagA phosphorylation leads to an activation of the oncoprotein and is associated with an
oncogenic progression of the infection.
First, CagA is translocated via the T4SS of H. pylori into the host cells. Zhao et al. pub-
lished that CEACAMs, rather than integrin receptors are essential for CagA translocation
into human gastric cells [128]. Here, it could be demonstrated that CEACAMs enhance
the amount of translocated CagA into neutrophils. Humanized neutrophils showed a
higher amount of CagA translocation in comparison to wt mouse neutrophils. Consistent
with these findings an infection with the ∆hopQ mutant strain resulted in a reduced CagA
translocation. This results might indicate that the HopQ-CEACAM interaction activates
a signaling cascade. However, Bonsor et al. analyzed the structure of HopQ-CEACAM
and speculated that still the ”dwell time” and the high affinity during the HopQ-CEACAM
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interaction is responsible for enhanced CagA translocation via CEACAMs [38]. In this
project H. pylori translocated a higher amount of CagA in hCEACAM1, 3, 6 neutrophils
compared to hCEACAM1 and hCEACAM3,6 neutrophils. Comparing hCEACAM1 and
hCEACAM3, 6 neutrophils, the amount of translocated CagA was nearly the same. But,
other adhesins of H. pylori such as BabA and SabA do not result in a higher CagA translo-
cation. Thus, HopQ seems to be special and might activate a signaling cascade.
Moreover, humanized neutrophils showed a higher amount of CagA translocation in com-
parison to human PMNs. A possible explanation could be the presence of other human
receptors on the surface of human PMNs that influence the process. In comparison to
human PMNs the humanized mouse PMNs only express the inserted human CEACAM
genes and produce human receptors on their surface. This enables an exclusive study of
these receptors, however effects of other human receptors that also might have effects are
excluded here. Thus, these in vitro experiments analyze the interaction of the bacterium
with neutrophils in a special situation, which is needed to understand the basic mecha-
nisms of interaction. In future in vivo experiments have to be performed to look at other
parameters that might influence the processes in an in vivo situation as well.
Subsequent to translocation CagA is phosphorylated, which is associated with an onco-
genic course of disease. For the first time it was demonstrated in this project that human
CEACAMs on humanized neutrophils enable a phosphorylation and activation of the on-
coprotein of H. pylori, whereas in murine wt neutrophils CagA is not phosphorylated.
These data further support the involvement of a signaling cascade, which is activated by
the HopQ-CEACAM interaction.
The mild pathology in mice might be related to the non-phosphorylation of CagA go-
ing along with non-activation of phosphorylation dependent signaling cascades in murine
PMNs. This indicates that the bacterium infecting normal mice is not able to manipu-
late murine PMNs. In human PMNs CagA is phosphorylated and is cleaved in 40 kDa
fragments for so far unknown reasons. In humanized PMNs CagA is cleaved, too. But,
there a full length product of CagA (135 kDa) was detected as well. Thus, it might be
that not all CagA is cleaved in humanized PMNs, because of the high amount of CagA.
This is consistent with the finding of a higher CagA translocation in humanized PMNs in
comparison to human PMNs.
Within the host cell CagA is phosphorylated by Src and c-Abl kinases [45], [49]. Their
activity in murine PMNs was proven in an in vitro phosphorylation experiment, as well as
the translocation of CagA with the ß-lactamase dependent reporter assay. However, CagA
is not phosphorylated in murine PMNs without human CEACAMs. The exact process of
CagA phosphorylation and all involved molecules are unknown so far. Hatakayama et al.
could show that SHP-1 dephosphorylates CagA in its EPIYA motif resulting in a decrease
of its oncogenicity [52]. Thus, experiments with PMNs with an inactivation or deletion of
SHP-1 were performed. But, these manipulations did not lead to a CagA phosphorylation
79
4. DISCUSSION
in murine PMNs. Consequently, it is still an ongoing project to solve the mechanism of
CagA phosphorylation.
4.1.3 H. pylori-CEACAM interactions change the chemokine
secretion of neutrophils
For many years it has been claimed that neutrophils only function as phagocytes for in-
vading pathogens. However, these cells are more complex. They can produce cytokines
like proinflammatory chemokines resulting in recruitment of further immune cells and
intervene in inflammation processes. H. pylori translocates via its T4SS CagA in gastric
epithelial cells (see section 4.1.2). In this process the T4SS activates the epithelial cells
to secrete IL-8 leading to the recruitment of PMNs. Proinflammatory cytokines such as
IL-1β, IL-6, IL-8 and TNFα, which were detected in in vitro cultured biopsy samples
of infected patients [58], [59], are characteristic of a H. pylori infection. Their release
recruits immune cells to the site of infection. Neutrophils are the first recruited cells.
They phagocytose the bacterium and produce ROS (see section 4.1.1). In addition, they
secrete chemokines to attract further immune cells.
In this work it was shown that CEACAM-humanized neutrophils produce significantly
more MIP-1α in comparison to murine neutrophils. Charmoy et al. could demonstrate
that MIP-1α is important for the recruitment of DCs. Pharmacological and genetic in-
hibition of the protein leads to a considerable reduction of the number of recruited DCs
[14]. Consequently, humanized PMNs in the H. pylori infected mouse should recruit more
immune cells, and destroy more tissue leading to a stronger inflammation. These sug-
gestions have to be proven in in vivo experiments. So far, Kusugami et al. studied the
MIP-1α concentration and the number of MΦ in infected versus uninfected people. They
revealed a significant higher concentration of MIP-1α in persons infected with H. pylori
and detected an increased number of recruited MΦ in the lamina propria [177]. The re-
sults of Kusugami et al. are consistent with the findings in this work and confirm the high
MIP-1α concentrations under in vitro infection conditions. In further migration experi-
ments it will be tested whether the chemokine MIP-1α changes the migration behavior of
PMNs in vitro.
Consistent with the findings of this work Islam et al. showed increased levels of MIP-1α
after 6 h of infection of N. gonorrhoeae in the upper genital tract of transgenic CEA-
CAM1 as well as CEABAC mice [166]. In addition, Sintsova et al. demonstrated a higher
concentration of MIP-1α in neutrophils of CEABAC mice infected with N. gonorrhoeae
compared to wt mice [167]. This indicates that CEACAMs contribute to an inflammatory
response. Moreover, Sintsova et al. showed that the CEACAM dependent transcriptional
response resulting in the release of MIP-1α is dependent on p38 MAPK [167].
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4.1.4 The role of CEACAM3 in a H. pylori infection
CEACAM3 is required for oxidative burst and phagocytosis of N. gonorrhoeae. In ad-
dition, binding of the bacterium to CEACAM3 results in release of proinflammatory
chemokines such as KC, MIP-1α and MIP-2 [113], [116], [167]. The chemokine release
attracts further neutrophils. After their activation by N. gonorrhoeae they produce ROS
resulting in tissue damage and inflammation. Sintsova et al. demonstrated that the
release of proinflammatory chemokines depend on TAK-1 activating NF-κB. Inhibition
of TAK-1 stops the chemokine release, the massive infiltration of neutrophils and con-
sequently tissue damage. However, the clearance of N. gonorrhoeae by phagocytosis of
PMNs is still active [167]. Taken together, CEACAM3 is involved in protection of the
host as well as damage of host cells and tissue.
However, in this project it was also demonstrated that CEACAMs enhance the proin-
flammatory response in an infection of H. pylori. Consequently, further neutrophils were
attracted and cause tissue damage and inflammation as well as in an infection of N. gon-
orrhoeae. Lamb et al. could show that CagA interacts with TAK-1, which is essential for
NF-κB activation in a H. pylori infection resulting in chemokine release [57]. Probably,
TAK-1 inhibition might stop the massive infiltration of neutrophils in a H. pylori infection
resulting in limited inflammation as well.
Zimmermann recently described CEACAM3 as a decoy receptor enabling the host to kill
invading pathogens, which tried only to bind to CEACAM1 to enter the host and suppress
the immune response [178], [101]. Human pathogens such as N. gonorrhoeae were phago-
cytosed after binding to CEACAM3 [116], [113]. However, in this work it was shown that
H. pylori seems to manage survival of phagocytosis especially in neutrophils expressing
CEACAM3 and 6. In comparison to CEACAM1, CEACAM3 emerged evolutionary later
and is exclusively expressed in highly developed apes and humans, which represent the
only host of H. pylori. Strains of the bacterium show a high genetic diversity. It would
be interesting to test different H. pylori strains and to compare sequence data with H.
pylori strain databases to see whether the bacterium adapted to the CEACAM3 receptor
over time.
4.1.5 CEACAMs play a major role on PMNs rather than on
MΦ and DCs
PMNs have only a short lifetime in comparison to DCs and MΦ. These short life time
requires immediate activity as well as functionality, whereas DCs and MΦ phagocytose
pathogens and develop to a mature cell. Then, as mature cells, MΦ and DCs interact
81
4. DISCUSSION
with B- and T- cells by presenting the antigens of the pathogens. However, H. pylori
manipulate the maturation of DCs. Interestingly, semimature DCs initiate the develop-
ment of naive T-cells to regulatory T-cells with suppressed activity [78]. As a result, the
adaptive immune response is down-regulated.
In the experiments with immature DCs and MΦ in this project no CEACAM dependent
effect was found. This is consistent with the low CEACAM expression in these cells. In
the literature there is nearly no evidence for CEACAM6 expression in DCs and MΦ. Only
in one paper from 1975 is written: ”Antisera directed against the antigen cross- reacting
with CEA strongly stain the cytoplasm of polymorphonuclear cells, myelocytes and in
mononuclear cells, which probably are macrophages” [179]. But, it is not clear whether
they really worked with macrophages.
For human CEACAM1 expression Yu et al. demonstrated in immature DCs by the an-
tibody D14HF11, recognizing CEACAM1, 3, 4, 5 and 6, only very low levels of human
CEACAM1. In mature human DCs cultivated for three days with CD40LT, Yu et al.
showed that the CEACAM1 expression doubled as compared to immature DCs. Gen-
erally, human CEACAM1 expression was low when compared to CEACAM1 levels in
B-cells [180]. Thus, it is questionable whether human CEACAM1 plays a role in mature
DCs and whether it plays a role in the manipulation of the adapted immune response, e.
g. B- and T- cells. It seems that H. pylori uses other receptors for its interaction with
DCs and MΦ. This is also supported by the fact that the bacteria are able to manipulate
DCs and suppress the adaptive immune response in the mouse model without recognizing
CEACAMs [78].
In contrast, CEACAMs play an important role for PMNs (see section 4.1.1-3). Human
and humanized PMNs express high amounts of CEACAM6 and moderate amounts of
CEACAM1. The expression of human CEACAM3 was detected in low levels, as already
reported by Chan [138], who constructed the transgenic CEABAC mouse and detected
CEACAM3 only occasionally in tissue neutrophils [138].
Moreover, in further experiments the role of CEACAMs on other cell types and subtypes
of immune cells, which could be very different from the MΦ and DCs used in this work,
has to be analyzed. Here, immature cells were used to mimic the conditions in a H. py-
lori infection, where the bacterium inhibits the maturation of DCs [78]. The CEACAM
expression and secretion of chemokines of stomach epithelial cells as well as tissue MΦ
and tissue DCs of humanized CEACAM mice should also be studied in future.
In addition, it would be interesting to study the secretion of IL-1β in wt and humanized
mice, because its production is induced in an H. pylori infection [181]. In summary, the
data presented in this work suggest that in a H. pylori infection CEACAMs are important,
especially for PMNs.
All in all, it could be shown that CEACAMs dramatically change the behavior of neu-
trophils in the interaction with H. pylori.
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4.1.6 Characterization of PMNs from naive versus H. pylori-
infected hosts
In addition to the data on the H. pylori PMN interaction from in vitro experiments also
first data with PMNs under in vivo conditions were obtained. In these experiments neu-
trophils were isolated from mice, which were infected for four weeks with a mouse adapted
H. pylori strain. In addition, PMNs isolated from the blood of individuals chronically in-
fected with the bacterium were also tested. It was demonstrated that H. pylori behaves
differently in the interaction with neutrophils isolated from naive versus chronically in-
fected mice and humans. The experiments revealed that H. pylori translocated a lower
amount of CagA in neutrophils of chronically infected mice and humans in comparison
to neutrophils of naive mice or humans. Moreover, neutrophils from chronically infected
individuals showed a lower CEACAM expression by flow cytometry analysis. It was pre-
viously known that co- and preinfections reduce the amount of CagA translocation of a
second infecting H. pylori strain [159]. Furthermore, Shikotra et al. could demonstrate
that human CEACAM6 is up regulated in an asthma model [182]. It has been shown that
individuals infected with H. pylori are protected from the development of asthma. One
reason for this might be the initiation of the T helper cell type 1 response by H. pylori
[79], because in asthma die T helper cell type 2 response is activated. Whether there is a
relationship to the down regulation of CEACAM6 in a H. pylori infection has to be shown
in future.
However, a higher number of volunteers would be necessary to really proof the interesting
findings in this work.
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4.2 Conclusion and outlook
In conclusion, this is the first study that points out the importance of human CEA-
CAMs on neutrophils for the interaction with H. pylori. It could be shown that human
CEACAMs enable the phosphorylation of the oncoprotein CagA in murine PMNs, which
represents a decisive part of a H. pylori infection. Phosphorylation leads to the activation
of translocated CagA and is associated with an oncogenic progression of the infection.
Moreover, it was demonstrated that humanized PMNs secrete high numbers of MIP-1α,
which might lead to a stronger infiltration of immune cells into the mouse stomach. Re-
cruitment of neutrophils to the gastric submucosa in high numbers might result in a
stronger proinflammatory response and a severe outcome of a H. pylori infection, because
of tissue damage by ROS production. Neutrophils expressing human CEACAM3 and 6
showed an enhanced ROS production and it was demonstrated that the bacterium sur-
vives phagocytosis in neutrophils expressing CECAM3 and 6.
Thus, H. pylori uses the interaction with CEACAMs to survive in neutrophils and to
induce a stronger inflammatory response. These findings improved the understanding of
the H. pylori infection.
Many different pathogens interact via CEACAMs of the host cells. Thus, the discover-
ies of this work also provide starting points for research on other human pathogens. A
disadvantage of working with PMNs is their short life time. Thus, for further studies
an ER-Hoxb8 neutrophil cell line expressing human CEACAMs was finally generated,
however, has not been studied yet. It has to be noted that an immortalized cell line can
be useful for many experiments, but never replaces primary cells. Furthermore, future
experiments studying the role of CEACAMs in H. pylori infections of Mongolian gerbils
could discover new roles of CEACAMs.
All in all, the findings of this thesis demonstrate the importance of human CEACAMs in
the interaction of H. pylori with neutrophils. Moreover, these first in vitro data indicate
that the humanized CEACAM mouse might be a new appropriate model organism for H.
pylori research.
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